1. Stem Cells and Regenerative Medicine

Single-cell transcriptomics reveals a new dynamical function of transcription factors during embryonic hematopoiesis

  1. Isabelle Bergiers  Is a corresponding author
  2. Tallulah Andrews
  3. Özge Vargel Bölükbaşı
  4. Andreas Buness  Is a corresponding author
  5. Ewa Janosz
  6. Natalia Lopez-Anguita  Is a corresponding author
  7. Kerstin Ganter  Is a corresponding author
  8. Kinga Kosim
  9. Cemre Celen
  10. Gülce Itır Perçin
  11. Paul Collier  Is a corresponding author
  12. Bianka Baying  Is a corresponding author
  13. Vladimir Benes  Is a corresponding author
  14. Martin Hemberg  Is a corresponding author
  15. Christophe Lancrin  Is a corresponding author
  1. European Molecular Biology Laboratory, EMBL Rome, Italy
  2. Wellcome Trust Sanger Institute, United Kingdom
  3. European Molecular Biology Laboratory, Germany
https://doi.org/10.7554/eLife.29312
Share this article
Cite this article
  1. Isabelle Bergiers
  2. Tallulah Andrews
  3. Özge Vargel Bölükbaşı
  4. Andreas Buness
  5. Ewa Janosz
  6. Natalia Lopez-Anguita
  7. Kerstin Ganter
  8. Kinga Kosim
  9. Cemre Celen
  10. Gülce Itır Perçin
  11. Paul Collier
  12. Bianka Baying
  13. Vladimir Benes
  14. Martin Hemberg
  15. Christophe Lancrin
(2018)
Single-cell transcriptomics reveals a new dynamical function of transcription factors during embryonic hematopoiesis
eLife 7:e29312.
https://doi.org/10.7554/eLife.29312
  2. Download BibTeX
  3. Download .RIS

Abstract

Recent advances in single-cell transcriptomics techniques have opened the door to the study of gene regulatory networks (GRNs) at the single-cell level. Here, we studied the GRNs controlling the emergence of hematopoietic stem and progenitor cells from mouse embryonic endothelium using a combination of single-cell transcriptome assays. We found that a heptad of transcription factors (Runx1, Gata2, Tal1, Fli1, Lyl1, Erg and Lmo2) is specifically co-expressed in an intermediate population expressing both endothelial and hematopoietic markers. Within the heptad, we identified two sets of factors of opposing functions: one (Erg/Fli1) promoting the endothelial cell fate, the other (Runx1/Gata2) promoting the hematopoietic fate. Surprisingly, our data suggest that even though Fli1 initially supports the endothelial cell fate, it acquires a pro-hematopoietic role when co-expressed with Runx1. This work demonstrates the power of single-cell RNA-sequencing for characterizing complex transcription factor dynamics.

https://doi.org/10.7554/eLife.29312.001

Introduction

Over the past decade, advances in high-throughput transcriptomics and DNA occupancy analyses have provided valuable insights into how transcription factors (TFs) regulate cell fate decisions and determine cell identity. It has become clear that during embryonic development, the expression of key TFs is strictly regulated, and it has been shown that the combinatorial expression of a relatively limited number of TFs is sufficient to establish (and potentially change) cell identity and differentiation through their action on the underlying gene regulatory networks (GRNs) (Iwafuchi-Doi and Zaret, 2016). In this context, bulk transcriptomics analysis and chromatin immuno-precipitation sequencing (ChIP-seq) were used to describe TF interactions, thereby providing GRN models (Dunn et al., 2014; Mullen et al., 2011). Recently, these techniques were successfully used to study the embryonic hematopoietic system in an in vitro embryonic stem cell (ESC) differentiation model (Goode et al., 2016).

However, the use of bulk cell populations constitutes an important limitation in our efforts to fully understand the GRNs. Although bulk transcriptomics can reveal crucial overall gene correlations between semi-stable cellular states, it cannot resolve subtler gene interactions occurring in complex transitional states. In addition, using a bulk approach makes it difficult to infer the direct consequences on the transcriptional landscape upon which these TFs are acting.

These limitations can be overcome by the use of single-cell approaches. Over the past five years, tremendous technical progress has been achieved in the field. Gene expression can be efficiently assessed at the single-cell level, making it possible to distinguish subpopulations within tissues and cell cultures (Kolodziejczyk et al., 2015; Scialdone et al., 2016). Single-cell transcriptomics has previously been used to unravel complex developmental transitions such as gastrulation (Scialdone et al., 2016), demonstrating that it is possible to determine combinations of TFs that are expressed at the single-cell level as cellular differentiation progresses.

In the present work, we applied single-cell transcriptomics approaches to the ontogeny of the blood system in the mouse embryo. The GRNs that are involved in the production of the hematopoietic stem and progenitor cells (HSPCs) at the origin of all blood cells are not well understood. During mouse embryogenesis, HSPCs are generated mainly in the yolk sac (YS), from E7–E7.5, and in the aorta-gonad-mesonephros (AGM) region, from E10.5. They emerge from the endothelial cells forming the vasculature, through a process called the endothelial to hematopoietic transition (EHT) (Boisset et al., 2010; Choi et al., 1998; Eilken et al., 2009; Lancrin et al., 2009; Zovein et al., 2008). It has been proposed that a heptad of seven TFs (Gata2, Runx1, Erg, Fli1, Lmo2, Lyl1 and Tal1) known to be essential for blood development form a transcriptional complex that is potentially involved in the generation of HSPCs. This proposal was based on bulk ChIP-seq analysis of the binding of these seven TFs to the regulatory elements of 927 genes in the HPC7 cell line (Wilson et al., 2010). Nonetheless, there was no direct evidence that all seven TFs were expressed together at the single-cell level during embryogenesis or that the heptad targets play a crucial role in development. Employing single-cell transcriptomics analysis and an in vitro ESC differentiation system that gives rise to blood cells, we addressed these questions and provided novel insights into the formation of HSPCs from endothelial cells. Our data show that during EHT, two sets of TFs have opposite effects that allow proper differentiation. Through the transition, Erg and Fli1 support the endothelial cell fate while Runx1 and Gata2 promote the hematopoietic one. Unexpectedly, we found that the endothelial transcription factor Fli1 could acquire a hematopoietic function when expressed together with the hematopoietic master regulator Runx1. This work shows that GRN analysis based on single-cell transcriptomics data can highlight biological aspects that are missed by classical bulk methods, emphasizing the power of single-cell approaches in the understanding of complex developmental transitions.

Results

Key transcription factors identify a population intermediary between endothelial and blood cells during EHT in vivo and in vitro

We performed single-cell quantitative RT-PCR (sc-q-RT-PCR) on 95 genes associated with hematopoietic, endothelial (Endo), and vascular smooth muscle (VSM) cells (Supplementary file 1). Single cells were sorted from YS and AGM dissected from mouse embryos at E9, E10.5 and E11. To enrich for cells undergoing EHT, we selected cells using both the endothelial marker VE-cadherin (VE-Cad) and the hematopoietic marker CD41 (Figure 1—figure supplements 1 and 2). Using hierarchical clustering, these cells could be separated into three major groups in both tissues: Endo cells, Pre-HSPCs, which expressed both hematopoietic and endothelial genes (Taoudi et al., 2008), and HSPCs (Figure 1A and B, Figure 1—figure supplements 1 and 2).

Figure 1 with 6 supplements see all
Download asset Open asset
Analysis of in vivo and in vitro EHT by single-cell qRT-PCR identified the expression of key TFs at the Pre-HSPC stage.

(A) Principal component analysis (PCA) plot showing the cells isolated at E9, E10.5 and E11 from AGM and YS according to the indicated sample clusters (SC). For each tissue, each time point represents one experiment. (B) PCA plot showing the Gfi1–/– Gfi1b–/– GFP+ YS cells mixing with Pre-HSPCs group (black ellipse). Note that the PC2 axis has been reversed. (C) Experimental workflow used to differentiate in vitro ESCs into blood cells. BL-CFC, blast colony forming cells; EB, embryoid body; FACS, fluorescence-activated cell sorting. (D) PCA plot showing the four groups of cells coming from in vitro differentiated ESCs. (E) Heatmap showing average expression of endothelial (blue), hematopoietic genes (red) and seven key TFs (black) in the four groups found in vivo. The black rectangle highlights the expression of the seven TFs. (F) Heatmap showing the average expression of endothelial (blue), hematopoietic (red), vascular smooth muscle genes (purple) and seven key TFs (black) in the four groups found after in vitro differentiation of ESCs. The black rectangle highlights the expression of the seven TFs. See also Figure 1—figure supplements 1–6, Supplementary file 1, 2, 3 and 11.

https://doi.org/10.7554/eLife.29312.002

While the frequency of each population of cells differed between tissues and time-points (Figure 1—figure supplement 3), groups were more strongly correlated (Pearson r > 0.9) to their counterparts than to other groups in the same tissue and clustered together using principal component analysis (PCA) and hierarchical clustering (Figure 1—figure supplement 4 and Figure 1A).

In addition, E9.5 YS Gfi1–/–-Gfi1b–/–- cells, which are incapable of completing EHT due to the lack of the two transcriptional repressors Gfi1 and Gfi1b (Lancrin et al., 2012), clustered together with the Pre-HSPCs, reinforcing the notion that this population is an essential intermediary step between Endo and HSPCs (Figure 1—figure supplement 5 and Figure 1B).

EHT can be recapitulated in vitro using the ESC differentiation model (Huber, 2010). We performed a 3.25 day differentiation followed by isolation of Flk1+ cells, enriched in blast colony forming cells (BL-CFCs) (Choi et al., 1998), which were cultured for a further 1.5 days before performing sc-q-RT-PCR using the same 95 genes (Figure 1C). Hierarchical clustering identified four groups, corresponding to Endo, HSPCs, and Pre-HSPCs found in the embryonic vasculature and a fourth group characterised by high expression of Acta2 (smooth muscle actin) and Serpine1 and by low expression of endothelial and hematopoietic genes, which we identified as VSM (Figure 1—figure supplement 6A and Figure 1D).

In both the in vivo and in vitro systems, the most notable characteristic of the Pre-HSPCs population is the co-expression of seven genes coding for hematopoiesis-associated transcription factors: Erg, Fli1, Tal1, Lyl1, Lmo2, Runx1 and Gata2 (Figure 1E and F, Figure 1—figure supplement 6B and C), which have been proposed to work together as a complex (Wilson et al., 2010). By contrast, Endo cells expressed only Erg, Fli1, Lmo2 and Tal1 whereas HSPCs expressed Fli1, Lmo2, Lyl1, Runx1 and Tal1. This suggested that these seven TFs might be important in establishing and/or maintaining the cell-type identity of the Pre-HSPCs population.

Simultaneous overexpression of Erg, Fli1, Tal1, Lyl1, Lmo2, Runx1, Cbfb and Gata2 during hemangioblast differentiation leads to the formation of a population resembling Pre-HSPCs

The co-expression of the seven TFs in the Pre-HSPCs populations in vivo and in vitro prompted us to ask whether the co-expression of these genes could be linked to the identity of the Pre-HSPCs. To determine the effect of the expression of these seven factors at the single-cell level, we established an inducible ES cell line in which all seven genes and Cbfb, a protein that is essential for Runx1 DNA binding and function (Wang et al., 1996; Tahirov et al., 2001), could be expressed simultaneously following the addition of doxycycline (dox). We generated an inducible ES cell line (i8TFs) in which the eight coding sequences were linked together by T2A sequences (Figure 2A). This strategy exploits the ‘ribosomal skipping’ mechanism of the viral T2A peptide (Donnelly et al., 2001) to allow the production of eight proteins from a single transcript. The expression of all eight proteins was validated by western blot after 24 hr of dox treatment in ESC culture (Figure 2B). As a control, we created an ESC line, which does not contain any novel cDNA (Empty), but is otherwise identical to the i8TFs line.

Figure 2
Download asset Open asset
Generation of a doxycycline-inducible ESC line for the simultaneous expression of the eight transcription factors.

(A) Scheme showing the generation of the i8TFs ESC line. (B) Western blot showing the protein expression of the eight TFs after doxycycline (dox) treatment in the Empty line and in the i8TFs ESC line. See also Supplementary file 11.

https://doi.org/10.7554/eLife.29312.009

We studied the effect of the overexpression of the eight TFs during hemangioblast differentiation. After three days of EB culture, the Flk1+ cells were differentiated for one day in BL-CFC culture, at which time the cells have lost their mesoderm identity and have produced endothelial and vascular smooth muscle cells. Dox was added at this time point, and cells were cultured for two more days. Cells were imaged every 15 min for 48 hr and were harvested at the end of the culture for flow cytometry. The Empty cell line did not show any major difference, neither in terms of cell surface markers nor in terms of cell morphology after dox treatment. By contrast, we noticed a dramatic change following the activation of the eight TFs when almost all cells developed the same phenotype (VE-Cad+ CD41+ and cKit+ CD41+ depending on the staining) (Figure 3A). This change was accompanied by a marked decrease in the number of round cells (Figure 3B and Figure 3—figure supplement 1). The simultaneous expression of the eight TFs did not change the frequency of living cells (Figure 3C) but there was a 40% decrease in the number of cells in S phase, suggesting that the expression of the eight TFs has a negative impact on cell proliferation (Figure 3D).

Figure 3 with 5 supplements see all
Download asset Open asset
Hematopoietic differentiation of the i8TFs ESC line highlights the role of the eight transcription factors in the generation of Pre-HSPCs.

(A) Representative FACS plots of VE-Cad, cKit and CD41 expression after 3 days of BL-CFC culture of the indicated ESC lines (n = 3). (B) Graphs showing the average numbers of round cells counted per frame (n = 3) in a 48 hr time course for the indicated ESC lines. Error bars represent standard deviations. (C) Bar graph indicating the frequency of non-apoptotic living cells for the indicated ESC lines. Error bars represent standard deviations (n = 3). (D) Bar graph displaying the frequency of cycling cells for the indicated ESC lines. Error bars represent standard deviations (n = 3). (E) Bar graph displaying the number of hematopoietic colonies after replating cells in a colony-forming-unit assay from the indicated conditions. Error bars represent standard deviation (n = 4). ns, non significant. ** p-value<0.01 (paired two-tailed t-test). * p-value<0.05 (paired two-tailed t-test). See also Figure 3—figure supplement 1 to 5, Supplementary file 1, 4, 5 and 11.

https://doi.org/10.7554/eLife.29312.010

To evaluate the impact of the simultaneous overexpression of these eight genes on hematopoietic differentiation activity, we performed a colony-forming unit (CFU) assay. We plated the cells from both the i8TFs – dox and the i8TFs + dox conditions in the absence of dox in a medium that allows the growth of both myeloid and erythroid cells. We observed a dramatic increase in the number of colony-forming units from the +dox cells, suggesting that the induction of the eight TFs increases hematopoietic differentiation potential (Figure 3E).

The overexpression of the eight TFs led to the production of a majority of VE-Cad+ CD41+ cells (Figure 3A). However, at the beginning of dox treatment, the majority of cells were VE-Cad– CD41– (Figure 3—figure supplement 2A), which were enriched in vascular smooth muscle cells (named eVSMs) (Figure 3—figure supplement 2B). To understand the impact of the expression of the eight TFs on the two main non-hematopoietic populations — the VE-Cad+ CD41- endothelial population (named Endo) and the eVSM — we isolated Endo and eVSM cells at day 1 of BL-CFC culture (Figure 3—figure supplement 2A) and cultured them in hemogenic endothelial (HE) culture conditions with or without dox for 48 hr. Using flow cytometry, we showed that both populations were affected by the dox treatment and became almost entirely VE-Cad+ CD41+ (Figure 3—figure supplement 2C). Furthermore, the CFU-assay showed an increased hematopoietic differentiation capacity for the Endo +dox compared to the –dox condition, confirming their successful conversion (Figure 3—figure supplement 2D). By contrast, the eVSM cells did not show a comparable effect, and together with the flow cytometry data, this evidence suggests that even though the eVSMs gained the Pre-HSPCs phenotype, they probably remained more immature than the Endo +dox cells (Figure 3—figure supplement 2D). To further characterize the effect of the eight TFs on the eVSM and Endo populations, we carried out a microarray analysis on i8TFs eVSM and Endo conditions before (t0) and 24 hr after differentiation with or without dox treatment (+dox and –dox) (Supplementary file 5). The Empty ESC line eVSM was used as control. As expected, the dox treatment of these cells had little effect on the transcriptome as shown by PCA (Figure 3—figure supplement 3A). By contrast, the expression of the eight TFs changed the Endo and eVSM cells dramatically. Interestingly, the eVSM +dox group clustered closely to the Endo -dox and Endo +dox conditions but far apart from the eVSM -dox group. Differentially expressed gene (DEG) analysis highlighted the genes responsible for these changes (Figure 3—figure supplement 3B and Supplementary file 5). Gene ontology (GO) analysis of the DEGs showed that overexpression of the eight TFs led to the reduced expression of genes involved in vasculature and heart development, while there was an increase in the expression of genes linked to immune system and vasculature development for eVSM (compatible with the dual endothelial-hematopoietic identity of Pre-HSPCs) and cellular detoxification as well as vesicles for Endo (Figure 3—figure supplement 4A). Surprisingly, when comparing these DEGs with the 927 targets of the heptad identified by ChIP-seq, the overlap was only 26 genes (Figure 3—figure supplement 4B and C). This would suggest that the DEGs that we observed were not a direct consequence of the complex of eight TFs binding at the regulatory elements of these genes.

To find out whether the striking effect of the eight TFs is really due to the expression of several of these genes and not to the effect of one particular transcription factor, we generated eight inducible ESC lines for each of the single transcription factors (i1TF) (Figure 3—figure supplement 5A). Inducible expression of each TF was confirmed using western blot (Figure 3—figure supplement 5B). Using the same experimental layout as that used previously for i8TFs and Empty ESC lines, we performed BL-CFC assays and FACS analyses with these eight new ESC lines and studied the effect of dox treatment on each of them. We found that none of the i1TF lines were qualitatively similar to the i8TFs (Figure 3—figure supplement 5C and D).

To better distinguish differentiated cell populations, we repeated the BL-CFC culture with –dox/+dox treatment for the ten cell lines followed by sc-q-RT-PCR of the 95 genes used previously (Figure 4 and Supplementary file 6). In total, 854 cells were processed using sc-q-RT-PCR and passed quality control. Six biologically relevant cell clusters could be identified using hierarchical clustering analysis, and they were assigned names based on the expression of specific marker genes (Figure 4A). The Endo, VSM and Pre-HSPCs groups were defined as before (Figure 1). On the other hand, HSPCs were split into three groups: Erythroid Progenitor Cells I and II (EryPCs_I and EryPCs_II, respectively) and Myeloid Progenitor Cells (MyePCs). EryPCs_I and EryPCs_II were characterized by the expression of erythroid genes such as Gata1 and Hbb-bh1. EryPCs_I appeared to be more immature than EryPCs_II because the cells still express a high level of Itgb3 and Pecam1. MyePCs were characterized by the expression of myeloid markers such as Sfpi1 (or Pu.1) and Itgam and by the lack of erythroid genes.

Figure 4 with 2 supplements see all
Download asset Open asset
Single-cell transcriptomics analysis of i8TFs and i1TF ESC lines.

(A) Hierarchical clustering showing the sc-q-RT-PCR results for 95 genes on the ten inducible ESC lines after three days of BL-CFC culture. The clusters were defined according to the intersection of the red dotted line with the dendrogram in the upper part of the heatmap. (B) Bar graphs displaying the cell number in each of the six clusters defined in (A) for the ten cell lines. Stars indicate significant differences for +dox conditions (see Supplementary file 6 for p-values). See also Figure 4—figure supplements 1 and 2, Supplementary file 1, 6 and 11.

https://doi.org/10.7554/eLife.29312.016

For each cluster, the number of cells per condition was calculated and each +dox condition was statistically compared to all –dox conditions (Figure 4B and Figure 4—figure supplement 1). This analysis confirmed that following dox addition, the i8TFs cells form a Pre-HSPCs population co-expressing endothelial and hematopoietic genes, as suggested by the flow cytometry results. By contrast, none of the other cell lines presented such a dramatic change. Induction of Gata2 increased the frequency of EryPCs_II population by ~4 fold (Figure 4B). On the other hand, overexpression of Erg and Fli1 gave rise to slightly more Pre-HSPCs (Figure 4B). The other i1TF ESC lines had negligible changes upon dox treatment (Figure 4B and Figure 4—figure supplement 1).

Our sc-q-RT-PCR results suggested that the cells were homogeneous after the induction of the eight TFs. To confirm this observation, we carried out single-cell RNA sequencing (sc-RNA-seq) on i8TFs –dox, i8TFs +dox, Empty –dox and Empty +dox cells using the iCELL8 platform (Figure 4—figure supplement 2A). Again, PCA showed that i8TFs + dox cells were clearly clustered separately from the other cells (Figure 4—figure supplement 2B). On the basis of the PC2 variance, we noticed that there is less variance for the i8TFs +dox cells compared to the other three conditions. Altogether, this would suggest that the i8TFs +dox cells are comparatively more homogeneous than the control cells.

In vitro generated Pre-HSPCs share similarities with AGM Pre-HSCs type I

To better characterize the i8TFs +dox cells compared to embryonic populations, we examined the expression pattern of CD41, CD43 and CD45 proteins together with VE-cad. It has been shown that these markers could define more precisely several intermediate stages in the EHT process: Pro-HSCs (VE-Cad+ CD41+ CD43– CD45–), Pre-HSCs type I (VE-Cad+ CD41+ CD43+ CD45-) and Pre-HSCs type II (VE-Cad+ CD41+ CD43+ CD45+) (Rybtsov et al., 2014). Our results show that around 99% of VE-cad+ cells in the i8TFs +dox condition have a phenotype similar to Pro-HSCs (Figure 5A and B). To verify this finding, we isolated from E10 AGM the Pro-HSCs and Pre-HSCs type I populations and performed sc-q-RT-PCR with our set of 95 genes (Figure 5—figure supplement 1A and B). Interestingly, we found that the Pro-HSCs population was heterogeneous. Although all cells express a high level of endothelial genes, only half express blood genes such as Runx1, Gfi1, Sfpi1 and Myb. By contrast, the Pre-HSCs type I is more homogenous. All cells express endothelial genes but at a lower level compared to Pro-HSCs. Moreover, all cells express hematopoietic genes (Figure 5—figure supplement 1B). When we analyzed these cells together with the in vivo data from Figure 1A and the cells from i8TFs –dox and +dox cultures, we noticed that about half of Pro-HSCs clustered with Endo, while the other part clustered with the Pre-HSPC (Figure 5C). On the other hand, the Pre-HSCs type I clustered with Pre-HSPCs. Surprisingly, in opposition to their Pro-HSCs phenotype, we found that the i8TFs +dox were very close to the Pre-HSCs type I (Figure 5C). This was confirmed when the analysis was done without the seven TFs (Figure 5—figure supplement 1C) and when the single-cell qRT-PCR data from the 1,660 cells from Figures 1, 4 and 5 were combined (Figure 5—figure supplement 2).

Figure 5 with 2 supplements see all
Download asset Open asset
The eight TFs induction gives rise to a cell population similar to Pre-HSCs type I.

(A) Representative FACS plots of VE-Cad, CD45, CD43 and CD41 expression after 3 days of BL-CFC culture of the i8TFs ESC line in the presence or absence of dox (n = 3). (B) Bar graphs showing the average percentage of the four different VE-Cad+ cell populations after three days of culture (n = 3). Error bars represent standard deviations. (C) PCA plot showing the sc-q-RT-PCR results for 95 genes combining the cells from the i8TFs cell line after three days BL-CFC culture with the results from cells collected from wildtype YS and AGM regions (Figure 1B) and from the E10 AGM Pro-HSCs and Pre-HSCs type I. Note that the PC2 axis has been reversed. The ellipse highlights i8TFs +dox. See also Figure 5—figure supplements 1 and 2, Supplementary file 1, 7, 8 and 11.

https://doi.org/10.7554/eLife.29312.019

In conclusion, although the i8TFs +dox cells had a phenotype similar to that of the Pro-HSCs, their transcriptional profile was more similar to Pre-HSCs type I.

Identification of gene regulatory network from single-cell RNA sequencing data

To determine how the induction of the 8TFs by dox treatment affected GRNs using single-cell-RNA-seq, we decided to focus on the VSM cells because, unlike the Endo population, they are not naturally undergoing EHT (Figure 3—figure supplement 2C). Indeed, between Endo +dox and Endo –dox, there was only a two-fold increase in VE-Cad+ CD41+ population. On the other hand, there was a tenfold increase in VE-Cad+ CD41+ population between eVSM +dox and eVSM –dox (Figure 3—figure supplement 2C). Moreover, this population shows the largest gene expression contrast in our microarray data upon dox treatment, facilitating the identification of the GRNs controlled by the eight TFs (Figure 3—figure supplement 3B). As in the microarray experiments, VE-Cad– CD41– cells were sorted at day 1 of BL-CFC culture and cultured in the absence or presence of dox for 24 hr. Subsequently, cells from the –dox and +dox conditions were pooled at a 1:1 ratio and put on a Fluidigm C1 chip. The Fluidigm system allowed a higher sensitivity than the Wafergen system, but it did not allow the processing of several conditions and a large number of cells at the same time. The experimental design whereby cells were mixed and loaded onto one chip minimized the technical variability that would invariably arise from using two separate chips (Figure 6—figure supplement 1A). We obtained two biological replicates, and from each chip 96 cells (192 cells in total) were isolated and sequenced together. To determine which cells were exposed to dox we used the expression of the transgene (Figure 6—figure supplement 1B). A PCA of the sequencing data showed that cells expressing high levels of the 8TFs transcripts clustered separately from those expressing low levels of these transcripts (Figure 6—figure supplement 1C).

To identify regulatory relationships for the eight TFs, we performed a network analysis using the generalized distance correlation measure, dcor statistic (Székely et al., 2007), together with its conditional version pdcor (Székely and Rizzo, 2014). This measure has the advantage of being able to detect both linear and non-linear relationships between the transcriptome and the seed genes. However, when only the eight TFs were used as seeds, the resulting network was very small with only five of the eight TFs represented (not shown). Thus, we expanded the set of seed genes to include Gata1, Gfi1b, Spi1 (or Pu.1), Ldb1 and Cbfa2t3, which are known to play important roles in hematopoiesis. Using this extended set of genes, we obtained a network that illustrated how the eight TFs indirectly interacted through a common regulatory pathway (Ferreira et al., 2005; Goardon et al., 2006; Imperato et al., 2015; Lancrin et al., 2012; Mylona et al., 2013). The directionality of the relationships, positive correlation or negative correlation, was defined using the sign of a two-tailed t-test (gene-pairs with p>0.05 were assigned to ‘other’). Finally, interactions between seed genes were identified by conditioning the ‘targets’ of each seed gene on the expression of each other seed gene. An interaction was inferred if the relationships between both seed genes and a particular ‘target’ gene increased in strength when conditioning on the other seed gene.

When visualizing the resulting network, we only plotted the seeds that interacted with at least with one other seed (black lines) and the gene targets of at least two seed interactions (Figure 6A). Consistent with evidence from the literature, our network reconstruction method reports a tight interaction between the seed factors, apart from Lbd1, they are all included in the resulting network. Furthermore, we observe a core network composed of Erg, Lyl1, Lmo2, Tal1, Gfi1b, and Gata1 with Fli1 and Runx1 on opposite ends of the periphery. Several of the genes that were identified as targets of the seed genes were also known from the literature; for example, Gpr56, which was upregulated in our microarray experiment after dox treatment (Figure 3—figure supplement 4C), and Nfe2 (Wilson et al., 2010; Woon Kim et al., 2011). Moreover, several of the targets had previously been identified as being differentially expressed following dox treatment (Figure 3—figure supplement 4C, Supplementary file 5).

Figure 6 with 1 supplement see all
Download asset Open asset
Single-cell transcriptomics analysis reveals the transcriptional networks involved in Pre-HSPCs generation.

(A) Network built from gene correlations. Gpr56 is highlighted with a red asterisk. (B) Centrality values for all the genes containing a heptad peak within 1 kb of the TSS that are significantly above the median. Gpr56 is highlighted with a red asterisk. (C) The upper part shows the ChIP-Seq data for the seven TFs from the Wilson et al. (2010) study in the Gpr56 locus. The y-axis shows reads displayed as density plots, which were generated by Wilson et al. (2010) and visualized using the Integrated Genome Browser software. The two putative enhancers are highlighted with red rectangles. The lower part shows the results of the transcriptional reporter assay for two potential heptad enhancers in Gpr56 locus using i8TFs ESCs treated for 24 hr with doxycycline. Error bars represent standard deviations (n = 3). See also Figure 6—figure supplement 1 and Supplementary file 11.

https://doi.org/10.7554/eLife.29312.022

Encouraged by the results from the dcor analysis, we carried out a genome-wide analysis. Since Dcor is a slow correlation method, it was computationally infeasible to calculate the global network with it. That is why we used Spearman correlation, a very fast correlation method. We combined the two datasets and kept all correlations where the absolute value of the average correlation was greater than 0.25 and where the sign was consistent across Remove Unwanted Variation (RUV) and Size Factors (SF) normalizations. This resulted in a network containing 7,262 genes and 163,474 edges of which 123,394 were positive and 40,080 negative. Importantly, 11 genes out of the 13 seed genes used in the previous analysis where found in this large network: Cbfa2t3, Fli1, Gata2, Lmo2, Erg, Tal1, Gfi1b, Gata1, Runx1, Spi1 and Lyl1. In addition, among the 145 genes containing heptad peaks within 1 kb of their TSS, 26 were found in the network, although this was not significantly more than expected by chance (p>0.1, Fisher-exact test).

To identify the most important genes in the network, we calculated three different centrality measures (degree, betweenness and eigen) (Figure 6B). The number of genes among the 11 seed genes with values above the median was significantly higher than that expected by chance for all three measures (degree p-value=0.0005, betweenness p-value=0.006, eigen p-value=0.03). Interestingly, for the 26 heptad targets, only the betweenness presented a higher number of targets above the median than would be expected by chance (p-value=0.04). This highlights the expected central role of the heptad targets by their position ‘in between’ the main players of the network.

As Grp56 appeared as a top candidate in our two network analyses, we chose it for further experiments (Figure 6C). Gpr56 has been shown to be expressed in the hematopoietic clusters of the aorta (Solaimani Kartalaei et al., 2015) and to be upregulated along the EHT (Goode et al., 2016). ChIP-seq data (Wilson et al., 2010) show that there are two Gpr56 regulatory elements bound by seven out of the eight TFs in the HPC7 cell line (Figure 6C). We selected these putative enhancers and cloned them in a plasmid upstream of the Firefly luciferase reporter gene. A gene reporter assay in the i8TFs ESC line demonstrated that the induction of the eight TFs led to a strong increase in luciferase gene expression with the two Grp56 enhancers (Figure 6C). In conclusion, we were able to infer GRNs based on sc-RNA-seq data. We identified the key players affected by the induction of the eight TFs, among which Gpr56 was a major target gene.

Gene regulatory network analysis reveals contrasting effects of Runx1 and Fli1

The simultaneous expression of the eight factors led to the formation of a population resembling Pre-HSPCs through their specific action on GRNs. It was not clear, however, why the cells were blocked in this normally ‘transient’ intermediate stage of the EHT. To unravel this, we applied our network analysis to a sc-RNA-seq dataset of endothelial cells and HSPCs, before and after the EHT, respectively (Pereira et al., 2016). We generated a network using the same seeds as before (Figure 6A), and the most striking feature of the new network is that Fli1 and Runx1 share several targets, but with opposing directions of correlation (Figure 7A). A genome-wide network analysis based on Spearman correlations showed a similar pattern in which 210 genes were correlated to both Fli1 and Runx1 but in opposite directions (Figure 7B and Supplementary file 9). Furthermore, GO analysis revealed that genes whose expression is positively correlated with Fli1 and negatively correlated with Runx1 (yellow rectangle) are enriched for the terms vascular development, angiogenesis and cell migration (Figure 7—figure supplement 1A). On the other hand, genes whose expression is positively correlated with that of Runx1 and negatively correlated with that of Fli1 (green rectangle) are associated with the GO term immune system process (Figure 7—figure supplement 1A). Hence, Runx1 is more associated with hematopoietic genes whereas Fli1 is more associated with vascular genes. Interestingly, ChIP-seq data from Wilson et al. (2010) showed that 77 out of the 210 are direct targets of both Runx1 and Fli1 (Figure 7—figure supplement 1B and Supplementary file 9). The observed opposite correlation could be due to the fact that most endothelial cells express only Fli1 and not Runx1, while HSPC co-express Runx1 and Fli1. There is indeed a clear shift in the relative expression of Fli1 compared to that of Runx1 between the two cellular stages (Figure 7—figure supplement 1C). In conclusion, our network analysis revealed that Fli1 and Runx1 are connected to 210 genes but with opposite correlations, which might be linked to the contrasting expression patterns of Fli1 and Runx1 and/or to the opposing functional properties of these TFs.

Figure 7 with 1 supplement see all
Download asset Open asset
Single-cell transcriptome analysis suggests that Runx1 and Fli1 have opposite functions during EHT.

(A) Network built from gene correlations found in the Peirera dataset (Pereira et al., 2016). (B) Heatmap displaying Spearman correlations between the 210 genes found to be correlated to Runx1 and Fli1. The hierarchical clustering analysis gave us three groups of genes highlighted by three rectangles of different colors. The top GO term for each group of genes is indicated. See also Figure 7—figure supplement 1 and Supplementary file 9.

https://doi.org/10.7554/eLife.29312.024

Gain of function analysis reveals a functional balance between Gata2/Runx1 and Erg/Fli1 TFs during the endothelial to hematopoietic transition

To find out whether Runx1 and Fli1 have opposite functional effects on the cell fate decisions occurring during EHT, we re-examined our i1TF gain-of-function analysis (Figure 3—figure supplement 5 and Figure 4B). According to these results, we identified two main groups of TFs. The first one includes Fli1 and Erg while the second one includes Runx1 and Gata2. Indeed, in +dox condition, iFli1 and iErg both displayed an increase in Endo population as well as Pre-HSPCs population, although at much lower level than with i8TFs (Figure 4B). By contrast, iRunx1 and iGata2 cells showed an increased frequency in the EryPCs_II population and a decrease in the MyePCs population in the +dox condition (Figure 4B). This result is consistent with the hypothesis that some of the eight TFs have opposing effects.

We next evaluated the functional consequences of the removal of Runx1/Gata2 or Erg/Fli1 from the 8TFs construct. We hypothesized that removing Runx1 and Gata2 would enhance the endothelial cell fate, whereas removing Erg and Fli1 would increase the hematopoietic cell fate. We consequently generated two additional ESC lines (Figure 8A). The first, i6TFs, contains 6TFs that are also found in i8TFs but is without Erg and Fli1. The second, i5TFs, lacks Runx1, Gata2 as well as Cbfb, crucial partner of Runx1. We performed ESC differentiation of these cell lines in the same way as before and analyzed the consequences of the overexpression of these two sets of TFs. Interestingly, the overexpression of the five TFs partly recapitulated the effect of overexpressing the eight TFs and led to a clear increase of the frequency of VE-cad+ CD41+ (Figure 8B). Remarkably, the frequency of the VE-Cad+ CD41– population was significantly increased too, in stark contrast to what we observed with the eight TFs (Figure 3A and Figure 8B). Consistent with this result, there was a clear decrease of the number of round cells formed during the BL-CFC assay (Figure 8C). By contrast, the overexpression of the six TFs only had a minor impact on the expression pattern of VE-cad and CD41 (Figure 8B). However, there was a clear increase of round hematopoietic cells as shown by image analysis, suggesting an enhancement of blood cell formation (Figure 8C). The observed impact of the induction on the number of round cells was confirmed specifically with endothelial cells isolated at day 1 BL-CFC and cultured for two days in the presence of doxycycline in HE medium (Figure 8D and Figure 8—figure supplement 1A). In addition, sc-q-RT-PCR performed on the i5TFs and i6TFs confirmed this duality (Figure 8E and Figure 8—figure supplement 1B). The i5TFs showed a decrease of EryPCs_I hematopoietic progenitors that was associated with an increase in Endo and Pre-HSPC populations, whereas the i6TFs showed an increase in the EryPCs_II population of hematopoietic progenitors (Figure 8E and Supplementary file 10).

Figure 8 with 1 supplement see all
Download asset Open asset
The Erg/Fli1 and Runx1/Gata2 groups of transcription factors have opposite functions during EHT.

(A) Scheme showing the i5TFs and i6TFs constructs used to generate the two inducible ESC lines missing Runx1, Gata2 and Cbfb, or Fli1 and Erg (respectively). (B) Representative FACS plots of VE-Cad, cKit and CD41 expression following three days of BL-CFC culture of the indicated ESC lines (n = 3). (C) Graphs showing the average numbers of round cells counted per frame (n = 3) in a 48 hr time course for the indicated ESC lines. Error bars represent standard deviations. (D) Representative pictures taken two days after HE culture of sorted VE-Cad+ CD41– (Endo) cells for the indicated cell lines. Round cells correspond to blood cells. The scale bar corresponds to 100 μm. (E) Bar graphs displaying the sc-q-RT-PCR results for the i6TFs and i5TFs ESC lines. See also Figure 8—figure supplement 1, Supplementary files 1, 10 and 11.

https://doi.org/10.7554/eLife.29312.026

In conclusion, these results suggest that Fli1 and Erg on one side and Runx1 and Gata2 on the other side have opposing effects on the cell-fate decisions in hematopoiesis leading to the formation of Pre-HSPCs.

Discussion

In this study, we used single-cell transcriptomics to define three main populations in the embryonic vasculature during blood formation: endothelial cells, pre-hematopoietic stem/progenitor cells and hematopoietic stem/progenitor cells. While these results were initially obtained with a single batch of embryos, all key patterns were reproduced in a separate batch in an additional study (Morgan Oatley, unpublished results). Despite slight timing differences, there were strong similarities in gene expression between the yolk sac and the AGM EHT, suggesting a similar process in both sites. However, due to the blood circulation, we cannot rule out cellular exchange between these two sites.

Bulk ChIP-seq analyses have suggested that Erg, Fli1, Tal1, Lyl1, Lmo2, Runx1 and Gata2 work together as a heptad (Wilson et al., 2010). Here, we show for the first time that the heptad genes are specifically co-expressed at the single-cell level within the Pre-HSPCs, and that this combination was not found in any other population along the transition. This specific co-expression may be conserved in the human species, as it was shown recently in the in vitro human EHT model system that the intermediate population between endothelial and blood cells co-expresses Runx1, Lyl1, Tal1, Gata2, Erg and Fli1 (Lmo2 was not assessed) at the single-cell level (Guibentif et al., 2017) similarly to the Pre-HSPC population that we described. In contrast to Guibentif et al. (2017), we investigated the functional meaning of the co-expression of these transcription factors. We showed that their enforced expression, together with that of Cbfb, during hematopoietic differentiation gave rise to Pre-HSPCs in culture. This suggests that the co-expression of the heptad genes is necessary for cells to reach the transient Pre-HSPCs stage before pursuing the transition.

These findings are consistent with the hypothesis of the existence of a heptad protein complex. Surprisingly, only ten percent of the differentially expressed genes are heptad targets and only ten percent of the heptad targets are differentially expressed. This suggests that the gene expression changes that we observed were not a direct consequence of the binding of the eight TFs complex at the regulatory elements of these genes. This implies that the formation of Pre-HSPCs is probably due to a combination of individual functions acting on the GRNs rather than to the sole action of an eight-protein complex.

To define these GRNs, we developed a bioinformatics pipeline for sc-RNA-seq data. We characterized the tight relationships involved in the formation of Pre-HSPCs, thereby giving directionality to the protein–DNA interactions previously identified by ChIP-seq (Goode et al., 2016; Wilson et al., 2010). Network analyses of the Pereira dataset (Pereira et al., 2016) together with our in vitro results revealed a new and unexpected opposite relationship between Runx1 and Fli1 functions. In addition, this network suggests that Gata2 and Lmo2 might act as cooperative co-regulators with Runx1 and Fli1, respectively (Figure 7A).

On the basis of our data and what is known in the literature, we propose the following model (Figure 9). Initially, the endothelial cell fate program is driven by Erg and Fli1, both ETS transcription factors, which is consistent with our functional analyses (Figure 3—figure supplement 5D and Figure 4) and studies published before (Asano et al., 2010; McLaughlin et al., 2001). In addition, Wilson et al. (2010) showed that more than 90% of the loci targeted by Fli1 are also targeted by Erg in the HPC7 cell line, suggesting functional redundancy. Then, the expression of Runx1 commenses and this — along with the expression of Gata2, which has pro-hematopoietic function — initiates the hematopoietic transcriptional program . Previous data support this functional interaction as Runx1+/−::Gata2+/− compound heterozygous embryos are not viable due to their severe hematopoietic defects, reinforcing the notion that the two proteins are involved in the same biological process (Wilson et al., 2010). At this intermediate Pre-HSPCs stage, endothelial genes are progressively downregulated as shown by our data. As Fli1 and Erg gene expression remain stable between the Endo and the Pre-HSPCs stages, this could be explained by a functional switch for these factors in favor of the hematopoietic cell fate and a decrease in the fraction dedicated to the maintenance of the endothelial program at the single-cell level. Specifically, Fli1 may be involved both in endothelial and hematopoietic gene expression depending on the cellular context. Indeed, in presence of Runx1, Fli1 could potentially activate common target genes such as Gfi1 and Gfi1b, which are involved in the repression of endothelial gene expression (Lancrin et al., 2012; Thambyrajah et al., 2016; Wilson et al., 2010). Alternatively (or concomitantly), Runx1 and Fli1 could bind together on endothelial gene loci as shown for Sox17 (Lichtinger et al., 2012) and repress their expression. On the other hand, Fli1 could switch its function upon physical interaction with Runx1, as shown during megakaryocytic differentiation where there is a synergistic transcriptional activation upon Fli1–Runx1 interaction (Huang et al., 2009).

Figure 9
Download asset Open asset
Model for the dynamical function of transcription factors during the formation of blood stem and progenitor cells.

Proposed model for the dynamical function of transcription factors during the endothelial to hematopoietic transition. The upper blue arrow section shows the balance between transcription factors along the transition. The middle section indicates the gene expression levels for the two sets of transcription factors. In the lower blue arrow section, a possible mechanism for the functional switch of Erg/Fli1 in presence of Runx1/Gata2 is depicted. During the transition, epigenetically closed hematopoietic gene loci are progressively opened and activated in the presence of Runx1/Gata2 together with Fli1/Erg while the endothelial loci are progressively closed through Gfi1 and Gfi1b transcriptional repression. The DNA-binding data combined with single-cell GRN analysis suggests a dual function for Fli1 that is dependent on the cellular context (see main text for full description).

https://doi.org/10.7554/eLife.29312.028

At the end of the EHT, in the HSPCs, the endothelial program is completely suppressed along with the expression of Erg. At this development stage, Fli1 is fully dedicated to the hematopoietic cell fate program and works with Runx1 to carry on blood cell development. This is supported by the observation that almost all the Runx1 target genes specific to the HSPCs are also bound by Fli1 (Supplementary file 9).

In conclusion, our work gives an important insight into the switch between endothelial and hematopoietic cell fates that is required for blood cell formation. We have identified the Pre-HSPCs as the pivotal stage in this process, at which a competition between developmental programs takes place at the single-cell level. The expression of the heptad of TFs is directly linked to this transitional stage. The balance of activity of Erg, Fli1, Gata2 and Runx1 appears to have the most important role in the EHT, whereas the Tal1/Lmo2/Lyl1 axis might have an essential role in priming it. Indeed, Tal1 acts as a repressor of alternative cellular programs such as the cardiac lineage and is actively needed to initiate the EHT (Lancrin et al., 2009; Org et al., 2015). In this context, our single-cell transcriptomics approach allowed us to shed light on an unexpected change in Fli1 activity as a consequence of Runx1 expression. This appears to be a critical process for the proper completion of the EHT. Conditions reinforcing the interaction between Runx1 and Fli1 would probably help to tilt the balance towards the hematopoietic cell fate. Likewise, preventing the Fli1–Runx1 interaction could potentially impair the formation of blood cells from endothelium.

More generally, a dual competing function for a unique transcription factor might be a key process for other developmental transitions such as the epithelial to mesenchymal transition. The bioinformatics approach that we have used in this work could be readily applicable to the study of other developmental processes and could help to address this type of question. Finally, the discrepancy observed between bulk and single-cell analyses in this work could also exist in other studies of TF complexes, which could prompt researchers in different fields to revisit previous assumptions using our approach.

Materials and methods

Experimental model and subject details

Animals

C57BL/6 N, Gfi1:GFP (Yücel et al., 2004) and Gfi1b:GFP (Vassen et al., 2007) mouse lines were used. Gfi1+/GFP and Gfi1b+/GFP were crossed with each other to generate Gfi1+/GFPGfi1b+/GFP animals. These animals were then used for timed mating to generate Gfi1GFP/GFPGfi1bGFP/GFP double-knockout embryos. Timed mating was set up and the morning of vaginal plug detection was considered day 0.5. Embryos were staged according to morphological properties. All experiments were performed in accordance with the guidelines and regulations defined by the European and Italian legislations (Directives 2010/63/EU and DLGS 26/2014, respectively). All mice were bred and maintained at the EMBL Rome Mouse Facility in accordance with European and Italian legislations (EU Directives 634/2010 and DLGS 26/2014, respectively).

Cell lines

Request a detailed protocol
Generation of inducible ESC lines

All doxycycline-inducible ESC lines were generated using the inducible cassette exchange method described previously (Iacovino et al., 2011; Vargel et al., 2016). For iCbfb, iRunx1, iLmo2, iGata2 and iFli1 ESC lines, the transcription factor coding sequences were tagged in 5’ with an 8His-tag and amplified by PCR from differentiated ESC cDNA. The 8His-tagged coding sequences were then inserted into a pGEM-t-easy before cloning into the p2lox plasmid. For iTal1, iLyl1 and iErg, the 8His-tagged coding sequences were synthetized and cloned into a pUC57 Simple by the GenScript Gene Synthesis Service (http://www.genscript.com/ gene_synthesis.html). The 8His-tagged coding sequences were then cloned from the pUC57 Simple into the p2lox plasmid. For each of the generated p2lox plasmids, a Kozak sequence was then added at the start codon by PCR cloning. The subsequent p2lox plasmids were used to transfect the A2lox.Cre ESC line and to generate the eight single-factor inducible ESC line as previously described (Vargel et al., 2016). For the i8TFs ESC line, three individual constructs were synthetized and cloned into a pUC57 plasmid by the GenScript Gene Synthesis Service. Construct one was composed of the coding sequence for V5-Erg-T2A-V5-Lmo2. Construct two was composed of the coding sequence for HA-Tal1-T2A-cmyc-Fli1-T2A-FLAG-Lyl1-T2A. Construct three was composed of the coding sequence for FLAG-Runx1-T2A-FLAG-Cbfb-T2A-HA-Gata2-T2A. All three constructs were flanked by a start codon and two stop codons, together with the proper restriction sites for cloning into the p2lox plasmid, in order to allow their individual use. They also contain specific restriction sites for their excision, the addition of any of the other constructs, or the removal of any of the factor sequences. Construct one together with the start codon and two stop codons was cloned into the p2lox plasmid. Then, Construct two was added between the start codon and Construct one by classic cloning. Finally, Construct three was added between the start codon and Construct two to obtain the p2lox-8TFs. This plasmid was then transfected into the A2lox.Cre ESC line for the generation of the i8TFs. For the i5TFs, the intermediate p2lox construct containing Construct one and Construct two was used to generate the ESC line. For the i6TFs, V5-Erg and cmyc-Fli1 were successively excised from the p2lox-8TFs by classic cloning to generate the p2lox-6TFs used for the generation of the inducible ESC lines. The empty ESC line was generated using the basic p2lox plasmid and following the same procedure. For each inducible ESC line, a clone was selected based on the induction of the transcript expression measured by qPCR and validated by western blot analysis.

Identification of cell lines

All cell lines used in this work were mESC lines. The Runx1+/hCD4 mESC line was generated in the group of Georges Lacaud by the corresponding author, Christophe Lancrin (Sroczynska et al., 2009a). All A2lox.Cre-derived mESC lines were generated from the A2lox.Cre mESC line, which was a gift from Michael Kyba who produced it in his laboratory (Iacovino et al., 2011). All A2lox.Cre-derived mESC lines were generated in our laboratory as described in the section ‘Generation of inducible ESC lines’. All ESC lines had proper stem cell morphology and were able to give rise to blood and endothelial cells after in vitro differentiation (Figure 1D, Figure 3, Figure 3—figure supplements 1 and 5, Figure 8 and Figure 8—figure supplement 1A). All the inducible mESC lines were verified by western blots and qPCR analysis (Figure 2, Figure 3—figure supplement 5, Figure 4 and Figure 8—figure supplement 1B).

All cell lines used in this manuscript were tested negative for mycoplasma contamination.

Maintenance and differentiation of ESC lines

Growth and differentiation of ESCs were performed as previously described (Sroczynska et al., 2009b2009). Briefly, ESCs were maintained on feeders in an ESC culture medium made of KnockOut DMEM (GIBCO) (supplemented with 1% Pen/Strep [GIBCO], 1% L-Glutamine [GIBCO] and 1% NEAA [GIBCO]), 15% FBS (PAA), 0.0024% 1 mg/ml LIF (The Protein Expression and Purification Core Facility, EMBL-Heidelberg) and 0.24% 50 mM 2-mercaptoethanol (GIBCO). For differentiation, ESCs were seeded on gelatin-coated plates (0.1% gelatin [BDH] in PBS for 20 min) for one day in the normal ESC culture medium and then for one day in a medium similar to the ESC medium but containing IMDM (Lonza) instead of the KnockOut DMEM and without NEAA supplement.

To obtain embryoid bodies (EBs), cells were subsequently harvested and cultured in petri dishes at a density of 0.3 × 106 cells per 10 cm2 dish with an EB medium made of IMDM (Lonza) (supplemented with 1% Pen/Strep [GIBCO] and 1% L-glutamine [GIBCO]), 0.6% transferrin (Roche, Italy), 0.039% MTG (Sigma) and 50 mg/µl ascorbic acid (Sigma). After 3–3.25 days, EBs were harvested and Flk1+ cells were sorted using MACS MicroBead Technology (Miltenyi Biotec). For hemangioblast differentiation, Flk1+ cells were then cultured on gelatin-coated plates at a density of 0.01 × 106 cells per cm2 in a medium made of IMDM (Lonza), 1% Pen/Strep (GIBCO), 1% L-glutamine (GIBCO), 10% FBS (PAA), 0.6% transferrin (Roche), 0.039% MTG (Sigma), 0.5% ascorbic acid (Sigma), 15% D4T supernatant (EMBL-Monterotondo), 0.05% VEGF (10 µg/ml) (R and D) and 0.1% IL-6 (10 µg/ml) (R and D). During the hemangioblast differentiation, the cell population could be sorted and further cultured in hemogenic endothelium culture conditions. For this purpose, sorted cells were seeded on gelatin-coated plates at a density of 0.015 × 106 cells per cm2 in a specific medium made of IMDM (Lonza), 1% Pen/Strep (GIBCO), 1% L-glutamine (GIBCO), 10% FBS (PAA), 0.6% transferrin (Roche), 0.039% MTG (Sigma), 0.5% ascorbic acid (Sigma), 0.0024% LIF (EMBL-Heidelberg), 0.25% SCF (20 µg/ml) (R and D), 0.1% oncostatin M (10 µg/ml) (R and D) and 0.01% bFGF/FGF2 (10 µg/ml) (R and D). To pursue the differentiation with a hematopoietic progenitor assay, cells were collected three days after Flk1 sort from the hemangioblast (or the hemogenic endothelium) culture and plated at a density of 3.3 × 103 cells per cm2 in a medium made of IMDM (Lonza), 1% Pen/Strep (GIBCO), 1% L-glutamine (GIBCO), 55% of 0.5 g/ml methylcellulose (VWR), 15% PDS (Antec), 10% PFMH-II (GIBCO), 0.6% transferrin (Roche), 0.039% MTG (Sigma), 0.5% ascorbic acid (Sigma), 0.5% SCF (20 µg/ml) (R and D), 0.1% IL-3 (25 µg/ml) (R and D), 0.1% GM-CSF (25 µg/ml) (R and D), 0.04% IL-11 (12.5 µg/ml) (R and D), 0.2% EPO (10 µg/ml) (R and D), 0.2% IL-6 (5 µg/ml) (R and D), 0.2% TPO (12.5 µg/ml) (R and D) and 0.05% MCSF (10 µg/ml) (R and D). Colonies were counted for three replicates after 10–12 days.

For doxycycline treatment of the inducible ESC line, doxycycline (Sigma) was added directly to the culture medium at a final concentration of 1 µg/ml for 24 or 48 hr.

Method details

Embryo dissection

Request a detailed protocol

Yolk sac and AGM dissections were performed as described before (Bertrand et al., 2005) and Robin and Dzierzak, 2005). Briefly, pregnant mice were killed by cervical dislocation between E9.0 and E11 of gestation. Uterine horns were collected; the maternal tissues were removed as well as the placenta to isolate the embryos. The yolk sac was torn gently and separated from the embryo proper by tearing off the umbilical and vitelline arteries. Then, the somite pairs of the embryos were counted to determine their developmental stage. To isolate the AGM, the head, tail, limb buds, ventral organs and somites were removed. Yolk sac and AGM samples from the same embryonic development stage were pooled together in the same tube. To generate single-cell suspension from the isolated tissues, AGM and yolk sac samples were subjected to collagenase (Sigma) treatment for 30 min. at 37°C. AGM and yolk sac cell suspensions were then used for flow cytometry.

Western blot analyses

Request a detailed protocol

ESCs were cultured for two passages on gelatin to remove MEFs before being treated with 1 µg/ml of doxycycline (Sigma) for 24 hr. For whole protein extracts, cells were harvested using TrypLE express (GIBCO), washed with PBS and lysed in RIPA buffer (Thermo Scientific) for 30 min at 4°C. Samples were then centrifuged for 5 min at high speed and pellets were discarded. Nuclear extracts were prepared using the Nuclear Extract kit (ActiveMotif) following the manufacturer's instructions. Protein concentration was measured using the Pierce BCA Protein Assay Kit (Thermo Scientific) and equal amounts of –dox and +dox protein samples were loaded onto NuPAGE Novex 10% or 12% Bis-Tris Protein gels (Life Technologies). Migration and wet transfer on a PROTRAN nitrocellulose membrane (PerkinElmer) were performed using the XCell SureLock Mini-Cell Electrophoresis System from Invitrogen. Membranes were stained with Ponceau S solution (Sigma) to control the transfer efficiency and protein amounts. The membranes were then washed with TBST (TBS [20 mM Tris-Base, 154 mM NaCl, pH 7.5], 0.1% Tween 20) and blocked with TBST +5% milk for 45 min at RT. Membranes were then incubated ON at 4°C with primary antibodies diluted in TBST +1% milk as follows: 1:2000 anti-FLAG (Sigma), 1:1000 anti-HA (Sigma), 1:2000 anti-V5 (Life Technologies), 1:5000 anti-Runx1 (Abcam), 1:5000 anti-Cbfb (Abcam), 1:2000 anti-Gata2 (Abcam), 1:2000 anti-Tal1 (Abcam), 1:2500 anti-Fli1 (Abcam), 1:5000 anti-Lyl1 (Abcam), 1:5000 anti-Erg (Abcam), 1:1000 anti-Lmo2 (Abcam), 1:2000 anti-His tag (Abcam), and 1:10000 anti-alpha-tubulin (Sigma) (the last being used as loading control). Following primary antibody incubation, the membranes were washed three times with TBST and incubated for 45 min with HRP-conjugated secondary antibodies diluted in TBST +1% nilk as follows: 1:10000 anti-Mouse HRP (GE Healthcare Life Sciences), 1:10000 anti-Rabbit HRP (Jackson) and 1:10000 anti-Rat HRP (GE Healthcare Life Sciences). The membranes were developed using the Amersham ECL Prime Western Blotting Detection Reagent (GE Healthcare Life Sciences).

Time-lapse photography

View detailed protocol

Cell differentiation cultures were imaged from the time of doxycycline addition. Phase-contrast time-lapse images were taken with the IncuCyte HD (Essen Biosciences) inside the incubator, every 15 min, three areas per well. Time-lapse videos were generated with the Fiji software (http://fiji.sc/Fiji) (Schindelin et al., 2012) using 10 frames per second. Images were analyzed by CellProfiler software (http://www.cellprofiler.org) (Kamentsky et al., 2011) to quantify the number of round cells with a customized pipeline written by Christian Tischer from the EMBL Heidelberg Advanced Light Microscopy Facility. For each time point, the average and standard deviation of counts from all three spots were calculated to make graphs with Microsoft Office Excel software.

Flow cytometry and cell sorting

Request a detailed protocol

Staining was done as described previously (Sroczynska et al., 2009b2009) and analyses were performed with a FACSCanto (Becton Dickinson) or a FACSAria (Becton Dickinson). Cell sorts were performed with a FACSAria (Becton Dickinson) or by using magnetic sorting (MACS MicroBead Technology, Miltenyi Biotec) and anti-APC MicroBeads (Miltenyi Biotech). The monoclonal rat anti-mouse antibodies used were anti-Mouse CD309 (FLK1) APC (Avas12a1, eBioscience), anti-Mouse CD41 PE (MWReg30, eBioscience), anti-Mouse cKit APC (2B8, eBioscience), and anti-Mouse CD144 (VE-Cadherin) eFluor 660 (eBioBV13, eBioscience). FACS data were analyzed using the FlowJo software (Tree Star, Inc.).

Cell-cycle assay

Request a detailed protocol

Cell-cycle assays were performed using the Click-iT Plus EdU Alexa Fluor 488 Flow Cytometry Assay kit from Molecular Probes following the manufacturer instructions. Briefly, cells from hemangioblast, or hemogenic endothelium, culture were treated with 10 µM of EdU for 1 hr. The cells were then harvested and stained with Ghost Dye Red 780 (Tonbo Biosciences) for live/dead staining before staining with cell surface marker antibodies (anti-Mouse CD41 PE [MWReg30, eBioscience] and anti-Mouse CD144 [VE-Cadherin] eFluor 660 [eBioBV13, eBioscience]). Stained cells were fixed and permeabilized, and the Click-IT reaction was performed following the manufacturer instructions. Finally, cells were stained with Hoechst for DNA labeling and analyzed with the FACSAria (Becton Dickinson). FACS data were analyzed using the FlowJo software (Tree Star, Inc.).

Apoptosis assay

Request a detailed protocol

Cells from hemangioblast culture were harvested and stained with anti-Mouse CD41 PE (MWReg30, eBioscience), anti-Mouse CD144 (VE-Cadherin) eFluor 660 (eBioBV13, eBioscience) and AnnexinV (eBioscience). Finally, cells were stained with Sytox Blue for DNA labeling and analyzed with the FACSAria (Becton Dickinson). FACS data were analyzed using the FlowJo software (Tree Star, Inc.).

Luciferase assay

Request a detailed protocol

Sequences from the two heptad peaks found in the Gpr56 locus (Wilson et al., 2010) were synthesized and cloned by the GenScript Gene Synthesis Service into a pGL4.10[luc2] reporter plasmid (Promega), with additional 50-bp sequences upstream and downstream to ensure proper peak coverage. The pGL4.74[hRluc/TK] Renilla reporter plasmid that was used to control for transfection efficiency was obtained from Promega. ESCs were plated on gelatin-coated plates (0.1% gelatin [BDH] in PBS for 20 min) and passaged twice to remove the feeders. Cells were then seeded in gelatin-coated 96-well plates at a density of 5,000 cells per well. Next day, the medium was changed and the cells were transfected with the Firefly luciferase reporter plasmids together with the Renilla luciferase reporter plasmid using the NanoJuice Transfection kit (Merck Millipore). After 24 hr, cells were treated with doxycycline (Sigma) for 24 hr and luciferase assay was performed using the Dual-Luciferase Reporter Assay System (Promega) and the POLARstar Omega device (BMG Labtech) following manufacturer's instructions.

mRNA microarray

Request a detailed protocol

Cells were collected and washed once with PBS. Total RNA was extracted with RNAeasy Plus Micro kit (Qiagen). Samples were then tested for quality with BioAnalyzer (Agilent) and their concentrations measured using Qubit (Life Technologies). They were hybridized on an Affymetrix GeneChip Mouse Gene 2.0 ST Array.

Single-cell quantitative RT-PCR

Request a detailed protocol

A maximum of 1 day prior to the experiment, 96-well plates (BioRad) were filled with 5 µl of 2x reaction mix from the CellsDirect One-Step qRT-PCR kit (Invitrogen). On the day of the experiment, cells were harvested and stained for FACS analysis. Cells from Anti-Mouse CD41 PE (MWReg30, eBioscience)/Anti Mouse CD144 (VE-cadherin) eFluor 660 (eBioBV13, eBioscience) staining were single-cell sorted in the pre-filled 96-well plates (BioRad) using the FACSAria system (Becton Dickinson). The plates were snap-frozen on dry ice immediately after sorting and stored at −80°C for a maximum of 1 week. To perform RT/Specific Target Amplification (RT/STA), 4 µl of a reaction mix — composed of 2.8 µl of Resuspension buffer, 0.2 µl of SuperScript III and Platinum Taq polymerase from the CellsDirect One-Step qRT-PCR kit (Invitrogen) and 1 µl of 500 nM outer primer mix (primer sequence list, see table below) — was added to each well. Plates were first incubated at 50°C for 15 min. followed by incubation at 95°C for 2 min. Then, they were incubated at 95°C for 15 s. followed by incubation at 60°C for 4 min. for 20 cycles. To prepare the sample mixes, 1/5x diluted cDNAs were mixed wiyj the loading reagent (Fluidigm) and SsoFastTM EvaGreen Supermix (Bio-Rad). In parallel, individual assay mixes were prepared as 5 μM inner primer mix, with DNA suspension buffer and the assay loading reagent (Fluidigm). After the priming of 96.96 dynamic array IFC (Fluidigm), the sample mixes and assay mixes were put together in the corresponding inlets and loaded into the chip. Finally, the chip was run in the Fluidigm Biomark HD system by using the Biomark Data Collection Software and the GE96 ×96PCR + Meltv2.pcl program.

To control for technical variation in our sc-qRT-PCR runs, we used the universal cDNA reverse transcribed by Random Hexamer: Mouse Normal Tissues (BioChain). It allowed us to detect consistently 93 out of our 95 genes of interest. A sample without DNA template was also run each time to test for unspecific PCR amplification.

The primer list is as follows:

Gene nameOuter forwardOuter reverseInner forwardInner reverse
Acta2aggcaccactgaaccctaagcacagcctgaatagccacatccaaccgggagaaaatgacatggcggggacattgaag
Acvr1cgagtgctaatgatgatggctttccccgtttcacagtggtcctcgttcccgattccccgagtgtggaagatgacgattccccgagtgtggaagatga
Acvr1batgctgcgccatgaaaacatctcgtgatagtcagagacaagccacattggctttattgctgctgacatgggtccaggtgccattatc
Acvr2agctggcaagtctgcaggtgatcagaaatgcgtccctttggaacccatgggcaggttggtatttatagcaccctccaacacctctg
Acvr2bgaagggctgctggctagatgaagttgccttcgcagcagcatcaattgctacgacaggcaggaaagtacacctgggggttctcctc
Acvrl1cgaattgcccatcgtgacctcaacgtggttgttgccgatatccaggtacgaagtcgcaatgtgctggtcaacgaagtcgcaatgtgctggtcaa
Adcy4cgatggtggcatcttgttccctacgttcagcttgggttccttcagtacgacattcccacgcctggctgtccgacattcccacgcctggctgtc
Atp2a3cgaccattgtggctgcagtagaacgtcccagaattgctgtgaggaacgagagggcagggccatctacacgagagggcagggccatctaca
Bmp4cagccgagccaacactgtgatgggatgctgctgaggttgaagtttccatcacgaagaacatctgggaggaaacgaaaagcagagc
Bmpr1aacgttcaccgaaagcccagctatcgcggatgctgccatcaaagaaacgcgcaggacaatagaatgttgacgcgcaggacaatagaatgttg
Bmpr2cagacggccgcatggagtatatgagccagacggcaagagctgcttgtgatggagtattatcccaatgtacccaatcacttgtgtggagactca
Cacna2d1acgccaatggttttagctggtgacacgtgattggccagtgacgttgaaacgagcaagttcaatggacaaatgtgacgagcaagttcaatggacaaatgtg
Cdh2atcaacaatgagactggggacatcacttccatgtctgtggcttgaacactgtggcagctggtctggattaacgtatactgttgcactttctctcg
Cdh5cgacaccatcgccaaaagagagaccgtcttagcattctggcggttcaccgaggatttggaatcaaatgcacatcgcgaggatttggaatcaaatgcacatcg
Cldn5tggcaggtgactgccttccttgcatgtgcccggtactctgaccacaacatcgtgacggcgcagaaccacgcacgacatccacag
Col4a2cgaccctggaagccctggatttacgttgtcttcccttaagtcccaacacgatggcagggatgcctggtcgatggcagggatgcctggt
Col4a5cgaggactctctgtggattggctacgtatgaagggagcggaacgaacgattcatgatgcatacaagtgcaggacgattcatgatgcatacaagtgcagga
Ctnnb1aactcctgcacccaccatcccagttcccgcaaaggcgcatgatggcctctgataaaggcaactgtgctgggcaaagggcaag
Dcaf12l1cgaaggcctccatggcaactaccgtggtggggagacccagaaaacgagcaggcctctggagctacgagcaggcctctggagcta
Dpysl3cgaccattgggaaggacaacttcaccgtcggccacaaactggttttcacgaccatccctgaaggcaccaatcgaccatccctgaaggcaccaat
Enggcctgactttctgggactccagctgctgaccacatgggctgtcacgccaggctgaagacactgacgtcatgccgcagctggagtag
Enpp1cgaccatgaaaggaacggcatcacgtaatttcctggcttcggatgaccgatcagcggtcccgtgtttcgatcagcggtcccgtgttt
Epoggttgtgcagaaggtcccagagggacaggccttgccaaactctgagtgaaaatattacagtcccagatatggcctgttcttccacctcca
Eportgaagtggacgtgtcggcagacagcgaaggtgtagcgcgtcaaccgggcaggagggacaccgccccgcaggttgctcagaa
Eps8cgaaggctgccatgcctttcaatcgtgctgttcctcgccacaaaacgctcctaatcaccaagtagataggaattatgacgctcctaatcaccaagtagataggaattatg
Ergtcccgaagctacgcaaagaatttggactgaggggtgaggtgtacaactaggccagatttaccttatgatgtggccggtccaggctgat
Esamcgaagtctatgtctgcaaggctcaacgtcccaacaaaagtgcccacaacgacagagtgggctttgccaagtcgacagagtgggctttgccaagt
Fam122bcgaagtttctccagctccttccccgtaaatgtcttggattgagaacaggaccgacaaccagaggatttggaaagcaatgcgacaaccagaggatttggaaagcaatg
Fbn1acgtggcggggaatgtacaaacacgtcagagctgtgtagcagtaaccacgactgtcagcagctacttctgcaaatcgactgtcagcagctacttctgcaaat
Fli1tgctgttgtcgcacctcagttttccttgacattcagtcgtgaggactcagggaaagttcactgctggcctatggtctgtatgggaggttgtg
Flrt2cgatgccgctctagcttcttcccgtagtggagagcagcctaggaacgaccggacccggttggattcgaccggacccggttggatt
Fmo1cgaaaccacgtgaattacggtgtatcgccttgatgctgggcttgatacgagctccagaagacaggactcacgagctccagaagacaggactca
Gata1cctgtgcaatgcctgtggcttgcctgcccgtttgctgacaagtatcacaagatgaatggtcagaacccattcgcttcttgggccggatg
Gata2aagcaaggctcgctcctgcacaggcattgcacaggtagtcagaaggccgggagtgtgtcgcccgtgccatctcgt
Gdpd5cgaacttccgacaactcccatacccgttgccgatgatgaggctgaacgatttctcgggtgccttctccacgatttctcgggtgccttctcca
Gfi1cgagagatgtgcggcaagacccgtagcgtggatgacctcttgaacgagtgagcctggagcaacacaacgagtgagcctggagcaacacaa
Gfi1bcgatggacacttaccactgtgtcacgtaggttttgccacagacatcaccgaagtgcaacaaggtgttctcccgaagtgcaacaaggtgttctcc
Gpr126cgactgtgcagccacttcactcacgtggcagatattccgcacccaatacgatggagttctgatggatcttcccgatggagttctgatggatcttcc
Gria4cgacgcccatggtgacgaaactacgtgccattaccaagacaccatcgtaacgatggatcgctggaagaaactagaacgatggatcgctggaagaaactaga
Hbb-bh1gagctgcactgtgacaagcttcaggggtgaattccttggcaaaatggatcctgagaacttcaagcgagtagaaaggacaatcaccaaca
Itga2bttccaaccagcgcttcaccttgctcggatccccatcaaaccgacaacagcaacccagtgtttgcccacggctaccgaatatc
Itgamagcaggggtcattcgctacgcagctggcttagatgcgatggattggggtgggaaatgccttcgtcgagctctctgcgggact
Itgb3tcctccagctcattgttgatgcaggcaggtggcattgaaggaacgggaaaatccgctctaaaagtgacagttcttccggcaggt
Kdrtgtggggcttgatttcacctgtcgccacagtcccaggaaagcactctccaccttcaaagtctcatcatttcacatcccggtttacaatcttc
Kitctggctctggacctggatgacctggctgccaaatctctgtgtgctgagcttctcctaccaggtgatacaattcttggaggcgaggaa
Lad1cgacctctttgagaaggagctgtcacgtcctgggtcttgctgatccacgaggccagaaccgcacagaaccgaggccagaaccgcacagaac
Latcgatgctgcctgacagtagtcccgttcactctcaggaacattcacgtacgactgccgtccctgttgtctcgactgccgtccctgttgtct
Lgr5cgagcaacaacatcaggtcaatacccgtcaggcaaatgctgaaaagcacgaggagcgagcgttcgtaggcgaggagcgagcgttcgtagg
Lmo2tcggccatcgaaaggaagaggcggtcccctatgttctgctctggacccgtctgaggaaccgcagccaccacatgtcagca
Lyl1gctgaagcgcagaccaagccatgctcacggctgttggtgaacactgtgagctggacttggctgacgccgagccaccttctggggttg
Meis2cgacccgtacccttcagaagaacagaacgttggtcaatcatgggctgcactacgagaaacagttagcgcaagacaccgagaaacagttagcgcaagacac
Metcgagatcattggtgcggtctcaatcgactcttgcgtcatagcgaaccgagtagttttgttattatccgggctcttcgagtagttttgttattatccgggctctt
Mpotggccctagacctgctgaagagttgacacggacaacagattcagcaagctgcagcccctgtgggagcaggtgtcaacacatctgtaa
Mybcgagtggcagaaagtgctgaacccgttgcttggcaataacagaccaaccgacatcaaaggtccctggaccaaacgacatcaaaggtccctggaccaaa
Myom1cgattccgtgtacgtgctgtcaacgttccgtcatcatccacactcacacgccaggcaggcgttggaaagacgccaggcaggcgttggaaag
Notch1cgaccaaccctgtcaacggcaaacgtatttgcctgcgtgctcacaacgatgcccctcggggtacacgatgcccctcggggtaca
Npr1cgacagatttgtgggagcttgtacccgtcgaaacatccagtccagggtacgagaccctcccaacatctgtatccgagaccctcccaacatctgtatc
Palldcgagcttcgcttcaaggaggaccgttctggctcctggatgttgaacgacttctgaacaatggccaacccgacttctgaacaatggccaacc
Pcdh12cgatggctgcttttgcggaactcgtggtttggtttgggctggaacgaggaacccggtggaggacgaggaacccggtggagga
Pdzd2cgacaacttggaaagccccaaaccgtgtccccatttcgtaccatcacgaagggcaacagtaaaatgaaactcaagcgaagggcaacagtaaaatgaaactcaag
Pecam1tgcggtggttgtcattggagctggacatctccacgggtttgtcatcgccaccttaatagttgcagtgtttggccttggctttcctc
Plcd1cgatggcttctccagtcctagcacgtcccacgttatggcggacaacgatctgggcaggcattctatgagatggcgatctgggcaggcattctatgagatgg
Ppiacgaccgactgtggacagctctaacgtagtgagagcagagattacaggaccgatttcttttgacttgcgggcattcgatttcttttgacttgcgggcatt
Ppp1r16bcgagcgtgtggatgtgaaggaccgtgatgtcctggcactgagactacgaatggctgggagcctctcgaatggctgggagcctct
Ptprbacgccaagagcggcaattatgcacgttgcacccaggacacctttaacgaccactccttcaccgaggaacgaccactccttcaccgaggaa
Ptprcggcttcaaggaacccaggaaatatgacaataactgtggccttttgctcattgctgcacaagggccccgggatgcagatcatcctccagaagtcatcaa
Ptprmcgacagacctcctccaacacatcatcgtctcgtctttcttagcagagtcccgatcagatgaagtgcgctgagcgatcagatgaagtgcgctgag
Ramp2tcccactgaggacagccttgtccttgacagagtccatgcaatcaaaagggaagatggaagactacgatcttgtactcataccagcaaggtaggaca
Runx1cgaactactcggcagaactgagaacgtacggtgatggtcagagtgaacgaatgctaccgcggccatgcgaatgctaccgcggccatg
Samd4cgaacagctccgtccagaagaccgtactccagcctattgttgatgtcaacgtcgctgcccgtgcataacgtcgctgcccgtgcata
Sash1cgattgatctcactgaggagccctatcgccatgttggtggcaacatcccgactgataagcatggccgttgtcgactgataagcatggccgttgt
Serpine1aaaacccggcggcagatccacttgttccacggccccatgagatgctatgggattcaaagtcaaccttggagagctggcggagggcatga
Sfpi1gtgggcagcgatggagaaagtgcagctctgtgaagtggttctcatagcgatcactactgggatttctccgggaagttctcaaactcgttgttg
Shecgaacatggaaccgtacgatgcatcgtcacagtctcccctggttcaacgtaacagaaatcagacgccgtggttacgtaacagaaatcagacgccgtggtt
Slacgacgaatcttccgtcttcccaactcgggtgagcacacagcatagaccgaactggtactacatctcaccaaggcgaactggtactacatctcaccaagg
Smad1tctcagcccatggacacgaacaccagtgttttggttcctcgtatgatggcgcctccactgcgcaactgcctgaacatctcctc
Smad2tgctctccaacgttaaccgaaatcagcaaacacttccccacctgccactgtagaaatgacaagaagacatgtaatacaagcgcactccccttc
Smad3ccaatgtcaaccggaatgcagtgaggcactccgcaaagacccgtggaacttacaaggcgacacccctccgatgtagtagagc
Smad4ttgcctcaccaccaaaacgtggaatgcaagctcattgtgaccatcttcagcaccacccgcctatggccagtaatgtccaggatg
Smad5aaccatggattcgaggctgtgtgacgtcctgtcggtggtactctgagctcaccaagatgtgtaccgctccccagcccttgacaaa
Smad6ttctcggctgtctcctcctgacttcacccggagcagtgatgagtacaagccactggatctgtccgattggagttggtggcctcggttt
Smad7ggaagatcaaccccgagctgtgagaaaatccattgggtatctggatgtgctgcaacccccatcacaaggaggagggggagactcta
Smad9gcacgattcggatgagctttgtgcagcggtccatgaagatggaagggctggggagcagagttctcgatccagcagggggtgct
Snai1cgatctgcacgacctgtggaaacgtgagcggtcagcaaaagcacgactctaggccctggctgcttcgactctaggccctggctgctt
Snai2cgagcacattcgaacccacacacgttgcagtgagggcaagagaaacgattgccttgtgtctgcaagacgattgccttgtgtctgcaaga
Sox7agaacccggacctgcacaacccgctctgcctcatccacatcggagctcagcaagatgcggtctcttctgggacagtgtcagc
Tal1accggatgccttccccatgttgcgccgcactactttggtgtccaacaacaaccgggtgaagaaggaccatcagaaatctccatctca
Tektccaaaggagaatggctcaggtccggattgtttttggccttcttccagaacgtgagagaagaaccatgttaagggccagagttcctga
Tgfb1acccccactgatacgcctgagcagtgagcgctgaatcgaatggctgtcttttgacgtcactggccctgtattccgtctccttgg
Tgfb2ggcatgcccatatctatggagttccagatcctgggacacacagcagacactcaacacaccaaagtcctcagggaagcggaagcttcgggattta
Tgfb3catgtcacacctttcagcccaatctccacggccatggtcatctgagacatactggaaaatgttcatgaggtgcattgtccactcctttgaatttga
Tgfbr1gcagacttgggacttgctgtgacatctagaacttcaggggccatgtcatgattctgccacagatacaaccttttagtgcctactctgtggtttgg
Tgfbr2tggccgctgcatatcgtcctgcatctttctgggcttccatttccatggacgcgcatcgccagcaatccgacttgggaacgtg
Thpoccgacgtcgaccctttgtcttgcccctagaatgtcctgtgctccctgttctgctgcctgcttgctctgttccgtctgggtttt
Upp1cgagaaggaagacgtgctctaccacgtatgaaggtgttcatccgggaacgattcaacctcagcactagcacaccgattcaacctcagcactagcacac

C1 single-cell RNA sequencing

Request a detailed protocol

After 6,500 cells in 13 µl of PBS were obtained using FACS enrichment, Fluidigm Suspension Reagent was added in a 3:2 ratio and gently mixed by pipetting. A Fluidigm C1 10–17 uM IFC Chip was primed, 5 µl of cell suspension mix was added to the cell inlet, and the chip was loaded into the C1 instrument. Annotation of cell capture was carried out on a brightfield microscope at 40x magnification and each captured site was noted for having single-cell capture, doublet cell capture or debris. Lysis, reverse transcription, and PCR reagents (Clontech Takara) were then loaded into appropriate inlets as per Fluidigm layout. ERCC spike-in controls (Ambion) were added at a dilution of 1:4000 within the lysis mix to gain limit of detection and normalization in downstream analysis. The IFC was loaded into the C1 instrument overnight using the mRNA-Seq RT and the Amp script, and ~3 µl of cDNA was harvested and diluted in 5 µl of Fluidigm C1 DNA dilution buffer. Size distribution and quantification of individual cDNA samples was obtained using an AATI Fragment Analyzer (AATI) and the cDNA concentration was diluted to 100 pg/µl in 10 mM Tris HCl pH 8.0 for library preparation. Illumina library preparation was carried out using the Nextera XT DNA system (Illumina), but volumes were reduced as per the modified Fluidigm C1 protocol. Tagmentation was performed on all 96 samples using 1.25 µl of cDNA (125 pg total concentration) combined with 2.5 µl of tagmentation buffer (TD) and 1.25 µl of Amplicon Tagment Mix (ATM), and incubated for 10 min at 55 degrees. After incubation, 1.25 µl of Neutrilize Tagment Mix (NT) was added. Illumina PCR barcoded indexes were combined to obtain 96 distinct combinations of i7 and i5 barcodes, and 2.5 µl of combined index was added along with 3.75 µl of Nextera PCR Mix (NPM). Samples were then put through 12 cycles of PCR as per the Illumina protocol. Each column was then pooled into a 0.2 mL 8-strip PCR tube and Ampure XP purification was performed, after which each pool was combined to obtain a single 96-sample multiplexed pool of barcoded library. The final sequencing library was quantified by Qubit (Life Technologies) and size distribution was measured on an Agilent BioAnalyzer. Samples were sequenced with the Illumina HiSeq 2000.

Wafergen single-cell RNA sequencing

Request a detailed protocol

Cells were stained with the Cell Viability Imaging kit (Molecular Probes), which contains Hoechst 33342 and propidium iodide, and afterwards were counted with the Moxi Z Mini Automated Cell Counter (ORFLO). Stained cell solution was diluted in a mix with diluent and RNase inhibitor (New England Biolabs) to 1 cell/50 nl for dispensing on the ICell8-chip (Wafergen) with the MultiSample NanoDispenser (Wafergen). Positive and negative controls were prepared according to the ICell8 protocol and dispensed with the MSND into the respective nanowells of the chip. All nanowells of the ICell8 chip were imaged with a fluorescence microscope (Olympus). The images were analyzed with the CellSelect software (Wafergen). Alive single cells, which are Hoechst-33342-positive and propidium-iodide-negative, were selected for lysis and reverse transcription inside the ICell8 chip (200 cells i8TFs + dox, 150 cells i8TFs –dox, 150 Empty –dox and 150 Empty +dox). RT reaction mix containing 5X RT buffer, dNTPs, RT e5-oligo (Wafergen), nuclease-free water, Maxima H Minus RT (Thermo Scientific) and Triton X-100 was prepared and dispensed into the previously selected nanowells with single cells inside. The chip was placed inside a modified SmartChip Cycler (Bio-Rad) for the RT reaction (42°C for 90 min, 85°C for 5 min, 4°C forever).

The cDNA of all single cells was collected together and further concentrated with the DNA Clean and Concentrator−5 kit (Zymo Research). The Exonuclease I (New England Biolabs) reaction of the cDNA (37°C for 30 min, 80°C for 20 min, 4°C forever) was performed inside a conventional thermal cycler. Afterwards, the cDNA was amplified with the Advantage 2 PCR Kit (Clontech Takara) containing buffer, dNTPs, Amp Primer (Wafergen), polymerase mix and nuclease-free water (95°C for 1 min, 18 cycles of 95°C for 15 s, 65°C for 30 s and 68°C for 6 min, followed by 72°C for 10 min and 4°C forever). The amplified cDNA was purified with Ampure XP Beads (Beckmann Coulter). The cDNA size distribution was obtained with the High Sensitivity DNA BioAnalyzer (Agilent) and quantification was performed with the Qubit (Life Technologies). Illumina library preparation was carried out by using Nextera XT DNA (Illumina). Tagmentation was performed in tagment DNA buffer, Amplicon Tagment Mix and 1 ng of purified cDNA (55°C for 5 min and 10°C forever), next Neutralize Tagment Buffer was added (room temperature for 5 min). After incubation, the Nextera®XT PCR reaction mix was prepared with Nextera PCR Mastermix, i7 Index Primer from the Nextera Index Kit (Illumina), Nextera Primer P5 and Tagmented cDNA-NT buffer mix (72°C for 3 min, 95°C for 30 s, 12 cycles of 95°C for 10 s, 55°C for 30 s and 72°C for 30 s, final 72°C for 5 min and 10°C forever). Ampure XP purification was performed with the finished library. The size distribution was checked on an Agilent BioAnalyzer. Samples were sequenced with the Illumina NextSeq.

Quantification and statistical analysis

GO term enrichment analysis

Request a detailed protocol

All GO term enrichment analyses were performed using the g:Profiler web server (Reimand et al., 2016).

Flow cytometry analysis

Request a detailed protocol

All flow cytometry experiments were independently repeated three times. For Figure 3C and Figure 3D, paired t-test was performed on the cell frequencies. For Figure 3—figure supplement 5D, frequencies for each population were plotted using JMP software (SAS). Error bars correspond to standard deviations.

Single-cell quantitative RT-PCR data analysis

Request a detailed protocol

Single-cell quantitative RT-PCR data were first processed with the Fluidigm Real Time PCR Analysis software (quality threshold, 0.65; Ct threshold, Auto (Global); and baseline correction method, linear [derivative]). Hierarchical clustering and PCAs were performed using the SINGuLAR Analysis toolset (Fluidigm version 3.5) package in R (R Core Team , 2016). Using this toolset, the Ct values were converted into log2ex. Ct value is a relative gene expression value in the log2 domain (assuming that the PCR efficiency is equal to 1). The conversion from Ct to log2ex value is based on the following formulae:

Log2ex = LOD – Ct, if Ct is less than the limit of detection (LOD)

Log2ex = 0, if Ct is equal to or greater than LOD.

Where the default is 24 (the typical Ct value for a single copy of input in the Fluidigm chip). In our case, the Ct value is a relative expression and does not have unit. Hence, following conversion to the Log2ex domain, we labelled the resulting values ‘Log2 Gene Expression’.

Hierarchical clustering and PCA analyses were performed with the HC() and PCA() functions of this package. The HC function clusters genes by the Pearson Correlation method, that is, co-profiled genes are clustered together and samples are clustered by normalized Euclidian distance (distance/number of genes), representing the average fold change. The HC analysis uses the ‘complete linkage’ method (a bottom-up method) to find similar clusters. The ‘global_z_score’ display option normalizes the expression value using the global mean and the global standard deviation.

The gene expression average of hematopoietic and endothelial genes is shown for each single cell in Figure 1—figure supplement 3. The hematopoietic average is based on the genes Epo, Epor, Gata1, Gata2, Gfi1, Gfi1b, Hbb-bh1, Itga2b, Itgam, Itgb3, Kit, Lmo2, Lyl1, Mpo, Myb, Ptprc, Runx1, Sfpi1, Sla, Tal1 and Thpo and the endothelial average on Cdh5, Cldn5, Eng, Esam, Fbn1, Gpr126, Kdr, Npr1, Pcdh12, Pecam1, Ptprb, Ptprm, Ramp2, Sox7 and Tek.

A prototype was calculated for each cluster group of single cells determined by the hierarchical clustering result shown in Figure 1—figure supplements 1 and 2. The prototype is defined by the average of all cells belonging to its cluster. The Pearson correlation coefficient between all pairwise prototypes is visualized in Figure 1—figure supplement 4A. The R package ComplexHeatmap was used (Gu et al., 2016).

A generalized linear model with Quasi-Poisson distribution and logarithm as the link function was applied to model the count table data as shown in Figure 4B. Six control groups were defined, one for each cell cluster category such as Endo or VSM. Each control group comprises 10 samples and includes all –dox conditions. For each cluster category and for each of the overexpression cell lines, the count of the +dox condition was compared to the counts in its respective control group. Out of these 60 statistical contrasts (six cluster categories times nine overexpression cell lines plus the cell line carrying an empty vector) five were identified to be significantly different with an adjusted p-value<0.05. The method of Benjamini-Hochberg was used for the multiple testing correction. In addition, the generalized linear model included an offset to model rates instead of counts. The rates account for small differences in the total number of cells measured on each of the processed well plates. All five significantly different conditions are marked with a star in Figure 4B (see Supplementary file 6 for p-values).

mRNA microarray data analysis

Request a detailed protocol

The mRNA microarray data were analyzed using oligo, phylobase, methods, biobase, stats, ggplot2, gplots, matrixstats, graphics, annotationdbi and limma packages in R (R Core Team , 2016).

C1 single-cell RNAseq data analysis

Request a detailed protocol

Each library was sequenced generating 426,065,795 and 440,774,932 paired-end reads (of 125 bp). Reads were assigned to the well with the matching barcode. Up to two mismatches are tolerated within the well barcode if the assignment remained non-ambiguous. STAR, version 2.4.0 (Dobin et al., 2013), aligned the reads to the mouse genome build mm10/GRCm38. Duplicate reads were removed using samtools, version 0.1.18 (Li et al., 2009). Wells with fewer than 1 million reads were deemed to be empty wells and excluded from further analysis (2 and 1, respectively). Reads with a minimum mapping quality of 30, which mapped to a unique gene, were counted using featureCounts, version 1.4.6 (Liao et al., 2014).

Read counts were normalized using RUVg, version 1.0.0 (Risso et al., 2014), using ERCC spike-in controls and size-factors (SF) as defined in DESeq (Anders and Huber, 2010). Cells with >7% of reads mapped to rRNA (three in each plate) and which were outliers on the basis of the first principal component after size factor normalization were excluded. The remaining cells all contained >7,000 detected genes and were used in all subsequent analyses.

We performed a network analysis using the generalized distance correlation measure, dcor statistic (Székely et al., 2007), together with its conditional version, pdcor (Székely and Rizzo, 2014). For each chip and each normalization method (four configurations), all significant relationships between the transcriptome and the seed genes were identified using the dcor statistic. The seed genes used for this analysis included the 8 TFs as well as Gata1, Gfi1b, Spi1, Ldb1 and Cbfa2t3. The additional seed genes were selected if they appeared in networks published by at least two different authors (Beck et al., 2013; Bonzanni et al., 2013; Moignard et al., 2013, 2015; Tanaka et al., 2012). The directionality of the relationships (positive correlation, negative correlation or ‘other’) was defined using a two-tailed t-test, direct was based on the sign of the test and ‘other’ was assigned to all genes with uncorrected p-value>0.05. To ensure robustness, we only included relationships that were identified in at least two of the four configurations, and any relationships with conflicting directionalities were assigned to ‘other’. Finally, interactions between seed genes were identified by conditioning the ‘targets’ of each seed gene on the expression of each other seed gene. An interaction was inferred if the relationships between both seed genes and a particular ‘target’ gene increased in strength when conditioned on the other seed gene.

For the Spearman network analysis, we combined Exp1 and Exp2 into a single expression matrix for each normalization (SF and RUV). We calculated Spearman correlations using base R-function for each normalization and we averaged the correlations across the two normalizations. We changed all correlations with absolute value <0.25 (i.e <0.25 and >−0.25) to 0. We created a network with weighted edges between genes, correlations of 0 = no edge. We calculated eigen centrality using eigen_centrality from the igraph R package (Bonacich, 1987). We took the absolute value of all edges (turns all relationships to be positive) and calculated betweenness centrality (number of shortest paths passing through a node) using betweenness from the igraph R package (Brandes, 2001). We calculated degree (number of edges attached to a node) using degree from the igraph R package. Then, we calculated the median value of each measure across all genes in the network. We counted the number of genes in the list that are above the median and we tested the significance of this using a binomial test (by definition 50% of genes are above the median).

Wafergen single-cell RNAseq data analysis

Request a detailed protocol

673 wells on the Wafergen chip passed microscopic inspection. Pooling, library construction and sequencing generated 179 million paired-end sequences using the Illumina Nextera protocol. Note that this shallower sequencing greatly reduces the detection rate of TFs, but the larger number of cells facilitated evaluation of heterogeneity within and between populations. The first read of the pair encodes the well barcode and the UMI (unique molecular identifier) barcode, the second encodes the 3′ end of the transcript. Reads were assigned to the well with the matching barcode. Up to two mismatches are tolerated within the well barcode if the assignment remained non-ambiguous. Cutadapt trimmed poly-A, poly-G and adapter sequences and STAR aligned the reads to the mouse genome build mm10 (Dobin et al., 2013; Martin, 2011). FeatureCounts determined all reads in a strand-specific way so that they overlap with exactly one gene (Liao et al., 2014). Gene expression levels are calculated by counting the number of distinct UMIs of all gene specific reads (‘UMIs per gene’), as determined by featureCounts. Only uniquely aligned reads were counted. To further reduce the impact of mapping and sequencing errors on the quantification, an UMI barcode error correction and filtering step was introduced. If two or more of the distinct UMIs per gene share a similar barcode, differing by at most one or two mismatches, then they may originate from the same UMI barcode. The UMI barcode is corrected only if it has less than 10% of reads compared to the most abundant one. This correction procedure starts with the UMI barcode, which is supported by the highest number of gene-specific reads, and which determines all similar barcodes and corrects them if applicable. It restarts with all UMI barcodes that have not been considered in a previous iteration until none is left. In a separate filtering step, any of the distinct UMIs per gene that is only supported by one or two aligned reads is completely omitted from the counting. From the resulting count table, all counts originating from the 23 control wells were removed for the subsequent explorative analysis. All remaining wells correspond to single cells. Additional filtering reduced the sparseness found in this gene per cell matrix of UMI counts. Only cells with 1000 or more genes with at least one UMI count and genes with at least one UMI count in 10 or more cells were selected, leaving a matrix of 478 single cells and 10,238 genes. This matrix was scaled and normalized with the Bioconductor package scater (McCarthy et al., 2017). The principal components were calculated for the 400 genes that showed the highest variance after subtracting the mean-variance trend of all genes. The explorative analysis was performed using R (R Core Team , 2016).

Data and software availability

Software

All software is freely or commercially available and is listed in the Methods description and product reference table.

Data resources

Request a detailed protocol

The accession number for all sc-RNA-seq and microarray data reported in this paper is GEO: GSE96986.

Product reference table

Request a detailed protocol
Product or resourceSupplierReference No
Antibodies
Anti-6X His tag antibody [HIS.H8]Abcamab18184
Anti-alpha-Tubulin-Antibody (mouse)SigmaT9026
Anti-APC MicroBeadsMiltenyi Biotec130-090-855
Anti-Cbfb AntibodyAbcamab133600
Anti-Erg AntibodyAbcamab92513
Anti-FLAG M2 antibodySigmaF1804
Anti-FLI1 antibody [EPR4646]Abcamab133485
Anti-GATA2 antibody [EPR2822(2)]Abcamab109241
Anti-HA antibody produced in rabbitSigmaH6908
Anti-Lmo2 AntibodyAbcamab91652
Anti-Lyl1 antibody [KT43]Abcamab53354
Anti-Mouse CD144 (VE-Cadherin) eFluor 660, eBioBV13eBioscience50-1441-80
Anti-Mouse CD309 (FLK1) APC, Avas12a1eBioscience17-5821-81
Anti-Mouse CD41 PE, MWReg30eBioscience12-0411-81
Anti-Mouse cKit APC AntibodyeBioscience17-1171-82
Anti-Mouse HRPGE Healthcare Life SciencesNA931V
Anti-Rat HRPGE Healthcare Life SciencesNA935V
Anti-Runx1 AntibodyAbcamab92336
Anti-Tal1 AntibodyAbcamab119754
Anti-V5 AntibodyLife Technologies46–0705
Peroxidase AffiniPure Goat Anti-Rabbit IgG (H + L)Jackson111-035-144
Chemicals
2-mercaptoethanolGIBCO31350–010
Ascorbic acidSigmaA4544
Collagenase Type IA from Clostridium histolyticum lyophilized powder (from sterile-filtered solution), 0.5–5.0 FALGPA units/mg solid, cell culture testedSigmaC9722-50MG
D4T supernatantEMBL-RomeN/A
DoxycyclineSigmaD9891
EPOR and D959-ME-010
ERCC RNA Spike-In MixAmbion4456740
Exonuclease INew England BiolabsM0293L
Fetal bovine plasma-derived serum platelet poor (PDS)AntechN/A
Fetal bovine serum (FBS)PAAA15-102
Fluidigm C1 DNA Dilution BufferFluidigm100–5317
Fluidigm Suspension ReagentFluidigm100–6201
GelatinBDH440454B
Ghost Dye Red 780Tonbo Biosciences13–0865
GM-CSFR and D425 ML
Human FGF basicR and D233-FB-025
IL-11R and D418 ML
IL-3R and D403 ML
IL-6R and D406 ML
IMDMLonzaBE12-726F
KnockOut DMEMGIBCO10829–018
L-glutamineGIBCO25030–024
LIFEMBL HeidelbergN/A
Maxima H Minus Reverse TranscriptaseThermo ScientificEP0752
MCSFR and D416 ML-010
MEM Non-Essential Amino Acids SolutionGIBCO11140–035
MethylcelluloseVWR9004-67-5
Monothioglycerol (MTG)SigmaM6145
Oncostatin MR and D495-MO
Penicillin-streptomycinGIBCO15140–122
PFMH-IIGIBCO12040–077
Pierce RIPA BufferThermo Scientific89900
Ponceau S SolutionSigmaP7170
RNase InhibitorNew England BiolabsM0314S
SCFR and D455-MC
TPOR and D488-TO-005
TransferrinRoche (Italy)10652202001
TrypLE expressGIBCO12605–036
VEGFR and D293-VE
Commercial assays
Advantage 2 PCR KitClontech Takara639207
Amersham ECL Prime Western Blotting Detection ReagentGE Healthcare Life SciencesRPN2232
Annexin V-FITC Apoptosis Detection KiteBioscience88-8005-72
Cell Viability Imaging kitMolecular ProbesR37610
CellsDirect One-Step qRT-PCR kitInvitrogen11753100
Click-iT Plus EdU Alexa Fluor 488 Flow Cytometry Assay kitMolecular ProbesC10633
DNA Clean and Concentrator−5 kitZymo ResearchD4013
Dual-Luciferase Reporter Assay SystemPromegaE1910
ICell8-chip and reagent kitWafergen430–000233
NanoJuice transfection kitMerck Millipore71902
Nextera Index KitIlluminaFC-131–1001
Nextera XT DNA Library Prep kit – 24 samples (Wafergen experiment)IlluminaFC-131–1024
Nextera XT DNA Library Prep kit – 96 samples (C1 experiment)IlluminaFC-131–1096
Nuclear Extract kitActiveMotif40010
Pierce BCA Protein Assay kitThermo Scientific23225
RNAeasy Plus Micro kitQiagen74034
SMARTer Ultra Low RNA Kit for the Fluidigm C1 System, 10 IFCsClontech Takara634833
Deposited data
Raw and analysed sequencing and microarray dataThis paperGEO: GSE96986
Raw and analysed sequencing data(Goode et al., 2016)GEO: GSE69101
Raw and analysed sequencing data(Pereira et al., 2016)GEO: GSE54574
Cell lines
A2lox.Cre mESC line(Iacovino et al., 2011)A2lox.Cre
A2lox.empty mESC lineThis paperEmpty
A2lox.i8TFs mESC lineThis paperi8TFs
A2lox.iCbfb mESC lineThis paperiCbfb
A2lox.iErg mESC lineThis paperiErg
A2lox.iFli1 mESC lineThis paperiFli1
A2lox.iGata2 mESC lineThis paperiGata2
A2lox.iLmo2 mESC lineThis paperiLmo2
A2lox.iLyl1 mESC lineThis paperiLyl1
A2lox.iRunx1 mESC lineThis paperiRunx1
A2lox.iTal1 mESC lineThis paperiTal1
Runx1+/hCD4(Sroczynska et al., 2009a)Runx1+/hCD4
Mice
C57BL/6NEMBL Rome
Gfi1b:GFP knock-in mice(Vassen et al., 2007)
Gfi1:GFP knock-in mice(Yücel et al., 2004)
Recombinant DNA
Plasmid: p2lox_5TFsThis paperp2lox_5TFs
Plasmid: p2lox_6TFsThis paperp2lox_6TFs
Plasmid: p2lox_8TFsThis paperp2lox_8TFs
Plasmid: p2lox_empty(Vargel et al., 2016)p2lox_empty
Plasmid: p2lox_K_CbfbThis paperp2lox_K_Cbfb
Plasmid: p2lox_K_ErgThis paperp2lox_K_Erg
Plasmid: p2lox_K_Fli1This paperp2lox_K_Fli1
Plasmid: p2lox_K_Gata2This paperp2lox_K_Gata2
Plasmid: p2lox_K_Lmo2This paperp2lox_K_Lmo2
Plasmid: p2lox_K_Lyl1This paperp2lox_K_Lyl1
Plasmid: p2lox_K_Runx1This paperp2lox_K_Runx1
Plasmid: p2lox_K_Tal1This paperp2lox_K_Tal1
Plasmid: pGL4.10[luc2]PromegaE6651
Plasmid: pGL4.74[hRluc/TK]PromegaE6921
Software and algorithms
CellProfiler(Kamentsky et al., 2011)http://www.cellprofiler.org
CellSelect softwareWafergenN/A
Fiji(Schindelin et al., 2012)http://fiji.sc/Fiji
FlowJoTree Star, Inc.N/A
JMP softwareSASN/A
Others
96.96 dynamic array IFCFluidigmBMK-M-96.96
AATI Fragment AnalyzerAATIDNF-474
Ampure XP BeadsBeckmann CoulterB23319
BioAnalyzerAgilentN/A
Biomark HD systemFluidigmN/A
FACSAriaBecton DickinsonN/A
FACSCantoBecton DickinsonN/A
Fluidigm C1 10–17 uM IFC chipFluidigm100–5760
Fluorescence microscope for Wafergen chip imagingOlympusBX43F
Hard-Shell PCR platesBio-RadHSP9611
HiSeq 2000IlluminaN/A
ICell8 SystemWafergenN/A
IncuCyte HDEssen BiosciencesN/A
MACS MicroBead TechnologyMiltenyi BiotecN/A
Moxi Z Mini Automated Cell CounterORFLOMXZ001
MultiSample NanoDispenserWafergenN/A
NextSeqIlluminaN/A
NuPAGE 12% Bis-Tris Protein GelsLife TechnologiesNP0343BOX
PCR barcoded indexesIlluminaFC-131–200
POLARstar Omega deviceBMG LabtechN/A
PROTRAN Nitrocellulose membranePerkinElmerNBA085C
QubitLife TechnologiesN/A
SmartChip CyclerBio-RadT-100
Universal cDNA Reverse Trancribed by Random Hexamer: Mouse Normal TissuesBioChainC4334566-R
XCell SureLock Mini-Cell Electrophoresis SystemInvitrogenN/A

Data availability

The following data sets were generated
The following previously published data sets were used

References

    1. Bertrand JY
    2. Giroux S
    3. Cumano A
    4. Godin I
    (2005)
    Hematopoietic stem cell development during mouse embryogenesis
    Methods in Molecular Medicine 105:273–288.
    1. Choi K
    2. Kennedy M
    3. Kazarov A
    4. Papadimitriou JC
    5. Keller G
    (1998)
    A common precursor for hematopoietic and endothelial cells
    Development 125:725–732.
  10. Software
    1. R Core Team 
    (2016)
    R: A language and environment for statistical computing
    R Foundation for Statistical Computing.
    1. Robin C
    2. Dzierzak E
    (2005)
    Hematopoietic stem cell enrichment from the AGM region of the mouse embryo
    Methods in Molecular Medicine 105:257–272.

Article and author information

Author details

  1. Isabelle Bergiers

    European Molecular Biology Laboratory, EMBL Rome, Monterotondo, Italy
    Contribution
    Conceptualization, Formal analysis, Supervision, Investigation, Visualization, Methodology, Writing—original draft, Project administration, Writing—review and editing
    For correspondence
    isabelle.bergiers@embl.it
    Competing interests
    No competing interests declared
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-9622-7960

  2. Tallulah Andrews

    Wellcome Trust Sanger Institute, Hinxton, United Kingdom
    Contribution
    Formal analysis, Visualization, Writing—review and editing
    Contributed equally with
    Özge Vargel Bölükbaşı
    Competing interests
    No competing interests declared
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-1120-2196

  3. Özge Vargel Bölükbaşı

    European Molecular Biology Laboratory, EMBL Rome, Monterotondo, Italy
    Present address
    Boston's Children Hospital, Boston, United States
    Contribution
    Investigation, Visualization, Writing—review and editing
    Contributed equally with
    Tallulah Andrews
    Competing interests
    No competing interests declared
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-4013-6343

  4. Andreas Buness

    European Molecular Biology Laboratory, EMBL Rome, Monterotondo, Italy
    Contribution
    Formal analysis, Visualization, Writing—review and editing
    For correspondence
    andreas.buness@embl.it
    Competing interests
    No competing interests declared

  5. Ewa Janosz

    European Molecular Biology Laboratory, EMBL Rome, Monterotondo, Italy
    Present address
    Institute of Experimental Hematology, Hannover, Germany
    Contribution
    Investigation, Writing—review and editing
    Competing interests
    No competing interests declared

  6. Natalia Lopez-Anguita

    European Molecular Biology Laboratory, EMBL Rome, Monterotondo, Italy
    Contribution
    Investigation, Writing—review and editing
    For correspondence
    natalia.lopez@embl.it
    Competing interests
    No competing interests declared

  7. Kerstin Ganter

    European Molecular Biology Laboratory, EMBL Rome, Monterotondo, Italy
    Contribution
    Investigation, Writing—review and editing
    For correspondence
    kerstin.ganter@embl.it
    Competing interests
    No competing interests declared

  8. Kinga Kosim

    European Molecular Biology Laboratory, EMBL Rome, Monterotondo, Italy
    Present address
    University of Sheffield, Sheffield, United Kingdom
    Contribution
    Investigation, Writing—review and editing
    Competing interests
    No competing interests declared

  9. Cemre Celen

    European Molecular Biology Laboratory, EMBL Rome, Monterotondo, Italy
    Present address
    UT Southwestern Medical Center, Dallas, United States
    Contribution
    Investigation, Writing—review and editing
    Competing interests
    No competing interests declared

  10. Gülce Itır Perçin

    European Molecular Biology Laboratory, EMBL Rome, Monterotondo, Italy
    Present address
    Technische Universität Dresden, Dresden, Germany
    Contribution
    Investigation, Writing—review and editing
    Competing interests
    No competing interests declared

  11. Paul Collier

    Genomics Core Facility, European Molecular Biology Laboratory, Heidelberg, Germany
    Present address
    Weill Cornell Medicine, New York, United States
    Contribution
    Investigation, Writing—review and editing
    For correspondence
    pgc2002@med.cornell.edu
    Competing interests
    No competing interests declared

  12. Bianka Baying

    Genomics Core Facility, European Molecular Biology Laboratory, Heidelberg, Germany
    Contribution
    Investigation, Writing—review and editing
    For correspondence
    baying@embl.de
    Competing interests
    No competing interests declared

  13. Vladimir Benes

    Genomics Core Facility, European Molecular Biology Laboratory, Heidelberg, Germany
    Contribution
    Supervision, Investigation, Writing—review and editing
    For correspondence
    benes@embl.de
    Competing interests
    No competing interests declared

  14. Martin Hemberg

    Wellcome Trust Sanger Institute, Hinxton, United Kingdom
    Contribution
    Conceptualization, Formal analysis, Supervision, Funding acquisition, Writing—review and editing
    For correspondence
    mh26@sanger.ac.uk
    Competing interests
    No competing interests declared

  15. Christophe Lancrin

    European Molecular Biology Laboratory, EMBL Rome, Monterotondo, Italy
    Contribution
    Conceptualization, Formal analysis, Supervision, Funding acquisition, Investigation, Visualization, Methodology, Writing—original draft, Project administration, Writing—review and editing, Lead Contact
    For correspondence
    christophe.lancrin@embl.it
    Competing interests
    No competing interests declared
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-0028-7374

Funding

EMBL Interdisciplinary Postdocs (EIPOD) Initiative (Post-doc fellowship)

  • Isabelle Bergiers

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Acknowledgements

We thank Georges Lacaud (University of Manchester) for the Runx1+/hCD4 ESC line; Michael Kyba (University of Minnesota) for the A2.lox.Cre ESC line; Tariq Möröy (Université de Montréal) for the Gfi1:GFP and Gfi1b:GFP mouse lines; Philip Hublitz (University of Oxford) for the design of the 8TF construct; Daniel Bilbao, Kalina Stantcheva and Cora Chadick (EMBL Rome FACS Facility) for cell sorting; Jelena Pistolic (EMBL Genomics Core Facility) for microarrays; Leo Chan and Mai Ho (WaferGen) for sc-RNA-seq; Gang Sun (Fluidigm) for advice on the SINGuLAR Analysis toolset; and Imre Berger (University of Bristol) and Philip Avner (EMBL Rome) for fruitful scientific discussions. The European Molecular Biology Laboratory, the EU Marie Curie Actions Cofund and the Wellcome Trust supported this work.

Ethics

Animal experimentation: All experiments were performed in accordance with the guidelines and regulations defined by the European and Italian legislations (Directive 2010/63/EU and DLGS 26/2014, respectively). All mice were bred and maintained at EMBL Rome Mouse Facility in accordance with European and Italian legislations (EU Directive 634/2010 and DLGS 26/2014, respectively).

Copyright

© 2018, Bergiers et al.

This article is distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 8,476
    views
  • 979
    downloads
  • 39
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Isabelle Bergiers
  2. Tallulah Andrews
  3. Özge Vargel Bölükbaşı
  4. Andreas Buness
  5. Ewa Janosz
  6. Natalia Lopez-Anguita
  7. Kerstin Ganter
  8. Kinga Kosim
  9. Cemre Celen
  10. Gülce Itır Perçin
  11. Paul Collier
  12. Bianka Baying
  13. Vladimir Benes
  14. Martin Hemberg
  15. Christophe Lancrin
(2018)
Single-cell transcriptomics reveals a new dynamical function of transcription factors during embryonic hematopoiesis
eLife 7:e29312.
https://doi.org/10.7554/eLife.29312

Share this article

https://doi.org/10.7554/eLife.29312

Categories and tags

Research organism

Further reading

    1. Stem Cells and Regenerative Medicine

    Rejuvenating aged osteoprogenitors for bone repair

    Joshua Reeves, Pierre Tournier ... Shukry J Habib
    Research Article

    Aging is marked by a decline in tissue regeneration, posing significant challenges to an increasingly older population. Here, we investigate age-related impairments in calvarial bone healing and introduce a novel two-part rejuvenation strategy to restore youthful repair. We demonstrate that aging negatively impacts the calvarial bone structure and its osteogenic tissues, diminishing osteoprogenitor number and function and severely impairing bone formation. Notably, increasing osteogenic cell numbers locally fails to rescue repair in aged mice, identifying the presence of intrinsic cellular deficits. Our strategy combines Wnt-mediated osteoprogenitor expansion with intermittent fasting, which leads to a striking restoration of youthful levels of bone healing. We find that intermittent fasting improves osteoprogenitor function, benefits that can be recapitulated by modulating NAD+-dependent pathways or the gut microbiota, underscoring the multifaceted nature of this intervention. Mechanistically, we identify mitochondrial dysfunction as a key component in age-related decline in osteoprogenitor function and show that both cyclical nutrient deprivation and Nicotinamide mononucleotide rejuvenate mitochondrial health, enhancing osteogenesis. These findings offer a promising therapeutic avenue for restoring youthful bone repair in aged individuals, with potential implications for rejuvenating other tissues.

    1. Genetics and Genomics
    2. Stem Cells and Regenerative Medicine

    A multiplexed, single-cell sequencing screen identifies compounds that increase neurogenic reprogramming of murine Muller glia

    Amy Tresenrider, Marcus Hooper ... Thomas A Reh
    Research Article

    Retinal degeneration in mammals causes permanent loss of vision, due to an inability to regenerate naturally. Some non-mammalian vertebrates show robust regeneration, via Muller glia (MG). We have recently made significant progress in stimulating adult mouse MG to regenerate functional neurons by transgenic expression of the proneural transcription factor Ascl1. While these results showed that MG can serve as an endogenous source of neuronal replacement, the efficacy of this process is limited. With the goal of improving this in mammals, we designed a small molecule screen using sci-Plex, a method to multiplex up to thousands of single-nucleus RNA-seq conditions into a single experiment. We used this technology to screen a library of 92 compounds, identified, and validated two that promote neurogenesis in vivo. Our results demonstrate that high-throughput single-cell molecular profiling can substantially improve the discovery process for molecules and pathways that can stimulate neural regeneration and further demonstrate the potential for this approach to restore vision in patients with retinal disease.

    1. Stem Cells and Regenerative Medicine

    Pharmacologically inducing regenerative cardiac cells by small molecule drugs

    Wei Zhou, Kezhang He ... Sheng Ding
    Research Article

    Adult mammals, unlike some lower organisms, lack the ability to regenerate damaged hearts through cardiomyocytes (CMs) dedifferentiation into cells with regenerative capacity. Developing conditions to induce such naturally unavailable cells with potential to proliferate and differentiate into CMs, that is, regenerative cardiac cells (RCCs), in mammals will provide new insights and tools for heart regeneration research. In this study, we demonstrate that a two-compound combination, CHIR99021 and A-485 (2C), effectively induces RCCs from human embryonic stem cell-derived TNNT2+ CMs in vitro, as evidenced by lineage tracing experiments. Functional analysis shows that these RCCs express a broad spectrum of cardiogenesis genes and have the potential to differentiate into functional CMs, endothelial cells, and smooth muscle cells. Importantly, similar results were observed in neonatal rat CMs both in vitro and in vivo. Remarkably, administering 2C in adult mouse hearts significantly enhances survival and improves heart function post-myocardial infarction. Mechanistically, CHIR99021 is crucial for the transcriptional and epigenetic activation of genes essential for RCC development, while A-485 primarily suppresses H3K27Ac and particularly H3K9Ac in CMs. Their synergistic effect enhances these modifications on RCC genes, facilitating the transition from CMs to RCCs. Therefore, our findings demonstrate the feasibility and reveal the mechanisms of pharmacological induction of RCCs from endogenous CMs, which could offer a promising regenerative strategy to repair injured hearts.